[{"year": "110-1-2", "id": "12970", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u95dc\u65bc\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\uff08Staphylococcus aureus\uff09\u81f4\u75c5\u56e0\u5b50\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u86cb\u767d\u8cea A\uff08protein A\uff09\u53ef\u8207\u514d\u75ab\u7403\u86cb\u767dIgG\u4e4bFc\u7d50\u5408\uff0c\u6291\u5236\u5bbf\u4e3b\u4e4b\u8abf\u7406\u53ca\u541e\u566c\u4f5c\u7528", "B": "\u8178\u6bd2\u7d20\uff08enterotoxins\uff09\u548c\u4e2d\u6bd2\u4f11\u514b\u75c7\u5019\u7fa4\u6bd2\u7d20-1\uff08toxic shock syndrome toxin-1\uff09\u70ba\u8d85\u7d1a\u6297\u539f\uff08superantigens\uff09", "C": "\u812b\u76ae\u6bd2\u7d20\uff08exfoliative toxin\uff09\u6703\u5f15\u8d77\u8868\u76ae\u71d9\u50b7\u75c7\u5019\u7fa4\uff08scalded skin syndrome\uff09", "D": "\u8461\u8404\u7403\u83cc\u6fc0\u9176\uff08staphylokinase\uff09\u4fc3\u9032\u7e96\u7dad\u86cb\u767d\u8cea\uff08fibrin\uff09\u7684\u5f62\u6210\uff0c\u963b\u7919\u541e\u566c\u7d30\u80de\u4f5c\u7528", "answer": "4"}, {"year": "110-1-2", "id": "12971", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u95dc\u65bc\u7d30\u83cc\u819c\u5b54\u86cb\u767d\u8cea\uff08porins\uff09\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u4e3b\u8981\u4f4d\u65bc\u5167\u819c\uff08inner membrane\uff09", "B": "\u53ef\u8b93\u89aa\u6c34\u6027\u5206\u5b50\u901a\u904e", "C": "\u8207\u5167\u6bd2\u7d20\uff08endotoxin\uff09\u529f\u80fd\u76f8\u4f3c", "D": "\u5c6c\u65bc\u7e96\u6bdb\uff08fimbriae\uff09\u86cb\u767d\u8cea", "answer": "2"}, {"year": "110-1-2", "id": "12972", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u95dc\u65bc\u55ae\u6838\u7403\u589e\u751f\u674e\u65af\u7279\u83cc\uff08Listeria monocytogenes\uff09\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u5177\u904b\u52d5\u6027\u4e4b\u9769\u862d\u6c0f\u967d\u6027\u83cc", "B": "\u7d55\u5c0d\uff08obligate\uff09\u80de\u5167\u5bc4\u751f", "C": "\u65bc\u651d\u6c0f4\u5ea6\u6642\u7121\u6cd5\u751f\u9577", "D": "\u4e3b\u8981\u7d93\u7531\u98db\u6cab\uff08aerosol\uff09\u50b3\u67d3", "answer": "1"}, {"year": "110-1-2", "id": "12973", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u6cbb\u7642\u7531\u5316\u81bf\u6027\u93c8\u7403\u83cc\uff08Streptococcus pyogenes\uff09\u6240\u5f15\u8d77\u7684\u8edf\u7d44\u7e54\uff08soft tissue\uff09\u75c5\u8b8a\u6642\uff0c\u4e0b\u5217\u4f55\u8005\u662f\u91ab\u8b77\u4eba\u54e1\u6703\u9762\u81e8\u7684 \u5927\u6311\u6230\uff1f", "qimg": "0", "A": "\u6b64\u75c5\u83cc\u5c0d\u9752\u9ef4\u7d20\uff08Penicillin\uff09\u6709\u6297\u85e5\u6027", "B": "\u6b64\u611f\u67d3\u75c7\u5e38\u5305\u542b\u591a\u7a2e\u7d30\u83cc\u611f\u67d3\uff08mixed infection\uff09\uff0c\u4e0d\u6613\u6cbb\u7642", "C": "\u53d7\u611f\u67d3\u7d44\u7e54\u7684\u8fc5\u901f\u58de\u6b7b\uff0c\u9032\u4e00\u6b65\u5f15\u8d77\u6557\u8840\u75c7\uff08septicemia\uff09", "D": "\u6b64\u75c5\u83cc\u5e38\u9020\u6210\u6301\u7e8c\u6027\u611f\u67d3\uff08persistent infection\uff09\uff0c\u4e0d\u6613\u6839\u9664", "answer": "3"}, {"year": "110-1-2", "id": "12974", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u95dc\u65bc\u70ad\u75bd\u687f\u83cc\uff08Bacillus anthracis\uff09\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u83a2\u819c\uff08Capsule\uff09\u662f\u6bd2\u529b\u56e0\u5b50\u4e4b\u4e00\uff0c\u5177\u6709\u6297\u541e\u566c\u4f5c\u7528", "B": "\u5176\u4fdd\u8b77\u6027\u6297\u539f\uff08Protective antigen, PA\uff09\u7576\u4f5c\u514d\u75ab\u539f\uff08immunogen\uff09\u7684\u6548\u529b\uff0c\u8f03\u6c34\u816b\u56e0\u5b50\uff08edema factor\uff09\u6216\u81f4\u6b7b\u56e0\u5b50\uff08lethal factor\uff09\u5dee", "C": "\u81f4\u6b7b\u6bd2\u7d20\uff08Lethal toxin\uff09\u5177\u91d1\u5c6c\u86cb\u767d\u9176\uff08metalloprotease\uff09\u6d3b\u6027", "D": "\u6c34\u816b\u6bd2\u7d20\uff08Edema toxin\uff09\u5177\u817a\u82f7\u9178\u74b0\u5316\u9176\uff08adenylate cyclase\uff09\u6d3b\u6027", "answer": "2"}, {"year": "110-1-2", "id": "12975", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u6709\u4e00\u75c5\u4eba\u56e0\u4e45\u54b3\u4e14\u75f0\u4e2d\u5e36\u6709\u8840\u7d72\u800c\u5c31\u8a3a\uff0c\u7d93\u91ab\u5e2b\u63a1\u96c6\u5176\u75f0\u6db2\u9032\u884c\u7d30\u83cc\u57f9\u990a\u6aa2\u6e2c\u5f8c\uff0c\u767c\u73fe\u7d50\u6838\u5206\u679d\u687f\u83cc\uff08Mycobacterium tuberculosis\uff09\u3002\u6709\u95dc\u6b64\u75c5\u83cc\u7279\u6027\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u8a72\u83cc\u70ba\u6297\u9178\u6027\u67d3\u8272\uff08acid-fast stain\uff09\u967d\u6027", "B": "\u8a72\u83cc\u67d3\u8272\u9ad4DNA\u4e4bG+C\u542b\u91cf\u8f03\u5927\u8178\u687f\u83cc\uff08Escherichia coli\uff09\u70ba\u9ad8", "C": "\u8a72\u83cc\u7d30\u80de\u58c1\u5bcc\u542b\u9ef4\u83cc\u9178\uff08mycolic acids\uff09", "D": "\u6b64\u83cc\u5728\u4eba\u9ad4\u5167\u4e3b\u8981\u5f15\u8d77Th-2\u578b\u514d\u75ab\u53cd\u61c9", "answer": "4"}, {"year": "110-1-2", "id": "12976", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u8fa8\u8b58\u5177\u6709\u6bd2\u529b\uff0c\u6240\u8b02\u795e\u5948\u5ddd\u8a66\u9a57\u967d\u6027\uff08Kanagawa-positive\uff09\u4e4b\u526f\u6eb6\u8840\u5f27\u83cc\uff08Vibrio parahaemolyticus\uff09\uff0c\u901a\u5e38\u662f\u4f9d\u64da\u6b64\u83cc\u6240\u7522\u751f\u7684\u4e0b\u5217\u90a3\u7a2e\u6210\u5206\uff1f", "qimg": "0", "A": "\u83a2\u819c\u591a\u91a3\u9ad4\uff08capsular polysaccharides\uff09", "B": "\u71b1\u4e0d\u5b89\u5b9a\u6027\u8178\u6bd2\u7d20\uff08heat-labile enterotoxin\uff09", "C": "\u71b1\u5b89\u5b9a\u6027\u6eb6\u8840\u7d20\uff08thermo-stable direct hemolysin\uff09", "D": "\u8102\u591a\u91a3\u9ad4\uff08lipopolysaccharides\uff09", "answer": "3"}, {"year": "110-1-2", "id": "12977", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u95dc\u65bc\u7b2c\u4e00\u578b\u4eba\u985e\u55dcT\u6dcb\u5df4\u7403\u75c5\u6bd2\uff08Human T-cell lymphotropic virus type 1, HTLV-1\uff09\u5f15\u8d77\u4e4b\u4eba\u985e\u6025\u6027T\u7d30\u80de\u767d\u8840\u75c5\uff08adult acute T-cell lymphocytic leukemia, ATLL\uff09\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u53ef\u7531\u8f38\u8840\u3001\u6027\u4ea4\u4ee5\u53ca\u54fa\u4e73\u50b3\u67d3", "B": "\u7d04\u4e00\u534a\u7684\u611f\u67d3\u8005\u6703\u7522\u751f\u6b64\u75c5", "C": "\u6cbb\u7642\u591a\u7528\u758a\u6c2e\u80f8\u82f7\uff08azidothymidine, AZT\uff09\u8207\u7532\u578b\u5e72\u64fe\u7d20\uff08interferon-\u03b1\uff09", "D": "\u6b64\u75c5\u4e4b\u9810\u5f8c\uff08prognosis\uff09\u5f88\u5dee", "answer": "2"}, {"year": "110-1-2", "id": "12978", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u4e0b\u5217\u4f55\u8005\u4e0d\u5c6c\u65bc\u53cd\u8f49\u9304\u75c5\u6bd2\u79d1\uff08Retrovirus family\uff09\uff1f", "qimg": "0", "A": "\u816b\u7624\u75c5\u6bd2\u4e9e\u79d1\uff08Oncovirinae\uff09", "B": "\u74b0\u72c0\u75c5\u6bd2\u4e9e\u79d1\uff08Orbivirinae\uff09", "C": "\u6162\u75c5\u6bd2\u4e9e\u79d1\uff08Lentivirinae\uff09", "D": "\u6ce1\u6cab\u75c5\u6bd2\u4e9e\u79d1\uff08Spumavirinae\uff09", "answer": "2"}, {"year": "110-1-2", "id": "12979", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u4e0b\u5217\u4f55\u7a2e\u65b9\u6cd5\uff0c \u4e0d\u80fd\u53bb\u9664\u5916\u79d1\u5668\u68b0\u4e0a\u7684\u50b3\u67d3\u6027\u86cb\u767d\u8cea\uff08prion\uff09\u4e4b\u611f\u67d3\u80fd\u529b\uff1f", "qimg": "0", "A": "\u9ad8\u58d3\u6ec5\u83cc 121\u2103\uff0c1\u500b\u5c0f\u6642", "B": "\u6d78\u6ce1\u65bc5%\u6b21\u6c2f\u9178\uff08hypochlorite\uff09\u6eb6\u6db2", "C": "\u6d78\u6ce1\u65bc1 M\u6c2b\u6c27\u5316\u9209\uff08NaOH\uff09\u6eb6\u6db2", "D": "\u7d2b\u5916\u7dda\u6d88\u6bd2", "answer": "4"}, {"year": "110-1-2", "id": "12980", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u95dc\u65bc\u4eba\u985e\u4e73\u7a81\u7624\u75c5\u6bd2\uff08Human papillomavirus, HPV\uff09\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u53ef\u4ee5\u611f\u67d3\u76ae\u819a\u4ee5\u53ca\u9ecf\u819c\u7d44\u7e54", "B": "\u6c92\u6709\u5916\u5957\u819c\uff08envelope\uff09", "C": "\u5176E1A\u8207E1B\u86cb\u767d\u8cea\u53ef\u4ee5\u6d3b\u5316\u81f4\u764c\u57fa\u56e0", "D": "HPV-16\u548cHPV-18\u5e38\u8207\u764c\u75c7\u7684\u5f62\u6210\u6709\u95dc", "answer": "3"}, {"year": "110-1-2", "id": "12981", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u95dc\u65bc\u809d\u708e\u75c5\u6bd2\uff08hepatitis viruses\uff09\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "A\u578b\u809d\u708e\u75c5\u6bd2\u8207C\u578b\u809d\u708e\u75c5\u6bd2\u7686\u70ba\u6b63\u80a1RNA\u75c5\u6bd2", "B": "B\u578b\u809d\u708e\u75c5\u6bd2\u8207C\u578b\u809d\u708e\u75c5\u6bd2\u7686\u6709\u5916\u5957\u819c\uff08envelope\uff09", "C": "A\u578b\u809d\u708e\u75c5\u6bd2\u8207E\u578b\u809d\u708e\u75c5\u6bd2\u5e38\u900f\u904e\u8840\u6db2\u50b3\u67d3", "D": "B\u578b\u809d\u708e\u75c5\u6bd2\u5728\u5bbf\u4e3b\u7d30\u80de\u6838\u5167\u8907\u88fd", "answer": "3"}, {"year": "110-1-2", "id": "12982", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u4e0b\u5217\u4f55\u8005\u70ba\u4eba\u985e\u514d\u75ab\u7f3a\u9677\u75c5\u6bd2\uff08Human immunodeficiency virus, HIV\uff09\u4e4b\u5957\u819c\u86cb\u767d\u8cea\uff08envelope protein\uff09\uff1f", "qimg": "0", "A": "gp120", "B": "gp21", "C": "p66", "D": "p55", "answer": "1"}, {"year": "110-1-2", "id": "12983", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u95dc\u65bc\u81f4\u75c5\u6027\u76ae\u766c\u83cc\uff08Dermatophytes\uff09\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u4e0d\u6703\u4eba\u50b3\u4eba", "B": "\u8868\u76ae\u766c\u83cc\u5c6c\uff08Epidermophyton\uff09\u4e0d\u7522\u751f\u5c0f\u5206\u751f\u5b62\u5b50\uff08microconidia\uff09", "C": "\u5c0f\u5b62\u766c\u83cc\u5c6c\uff08Microsporum\uff09\u6975\u5c11\u7522\u751f\u5927\u5206\u751f\u5b62\u5b50\uff08macroconidia\uff09", "D": "\u6bdb\u766c\u83cc\u5c6c\uff08Trichophyton\uff09\u7522\u751f\u5927\u91cf\u5927\u5206\u751f\u5b62\u5b50\uff08macroconidia\uff09", "answer": "2"}, {"year": "110-1-2", "id": "12984", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u4e0b\u5217\u4f55\u8005\u70ba\u591a\u70ef\u985e\uff08polyenes\uff09\u85e5\u7269\u6291\u5236\u771f\u83cc\u4e4b\u4e3b\u8981\u6a5f\u8f49\uff1f", "qimg": "0", "A": "\u76f4\u63a5\u8207\u9ea5\u89d2\u56fa\u9187\uff08ergosterol\uff09\u7d50\u5408\uff0c\u7834\u58de\u7d30\u80de\u819c\uff0c\u9020\u6210\u7d30\u80de\u8cea\u96fb\u89e3\u8cea\u4e0d\u5e73\u8861", "B": "\u6291\u523614-\u03b1-\u812b\u7532\u57fa\u9176\uff08Demethylase\uff09\uff0c\u4f7f\u7f8a\u6bdb\u753e\u9187\uff08lanosterol\uff09\u7121\u6cd5\u9032\u884cC14\u4f4d\u7f6e\u4e4b\u812b\u7532\u57fa\u53cd\u61c9", "C": "\u6291\u5236\u9bca\u70ef\u74b0\u6c27\u9176\uff08squalene epoxidase\uff09\uff0c\u4f7f\u9bca\u70ef\uff08squalene\uff09\u7121\u6cd5\u9032\u884c\u9589\u74b0\u4ee5\u5f62\u6210\u7f8a\u6bdb\u753e\u9187", "D": "\u6291\u52361,3-\u03b2-\u8461\u805a\u91a3\uff081,3-\u03b2-glucans\uff09\u4e4b\u5408\u6210", "answer": "1"}, {"year": "110-1-2", "id": "12985", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u771f\u83cc\u83cc\u7d72\uff08hyphae\uff09\u4e4b\u5169\u7a2e\u57fa\u672c\u5f62\u614b\u70ba\u4f55\uff1f", "qimg": "0", "A": "\u9694\u83cc\u7d72\uff08septate hyphae\uff09 \u548c\u591a\u6838\u9ad4\u83cc\u7d72\uff08coenocytic hyphae\uff09", "B": "\u9694\u83cc\u7d72\u548c\u767c\u82bd\u7ba1\uff08germ tube\uff09", "C": "\u5047\u83cc\u7d72\uff08pseudohyphae\uff09\u548c\u591a\u6838\u9ad4\u83cc\u7d72", "D": "\u5047\u83cc\u7d72\u548c\u9396\u72c0\u9023\u63a5\u83cc\u7d72\uff08clamp connection hyphae\uff09", "answer": "1"}, {"year": "110-1-2", "id": "12986", "type": "\u5fae\u751f\u7269\u5b78", "question": "\u76ee\u524d\u9810\u9632\u535a\u5fb7\u6c0f\u767e\u65e5\u54b3\u687f\u83cc\uff08Bordetella pertussis\uff09\u7684\u75ab\u82d7\uff0c\u4e3b\u8981\u7d44\u6210\u70ba\u4f55\uff1f", "qimg": "0", "A": "\u7121\u7d30\u80de\u75ab\u82d7\uff08acellular vaccines\uff09", "B": "\u8102\u591a\u91a3\u9ad4\uff08lipopolysaccharides\uff09", "C": "\u6e1b\u6bd2\u75ab\u82d7\uff08attenuated vaccines\uff09", "D": "\u83a2\u819c\u591a\u91a3\u9ad4\uff08capsular polysaccharides\uff09", "answer": "1"}, {"year": "110-1-2", "id": "12987", "type": "\u514d\u75ab\u5b78", "question": "\u963f\u5409\u6700\u8fd1\u5f97\u4e86\u6d41\u884c\u6027\u611f\u5192\uff0c\u4ed6\u807d\u8001\u5e2b\u8aaa\u75c5\u6bd2\u611f\u67d3\u6c92\u6709\u7279\u6548\u85e5\u53ef\u4ee5\u5403\uff0c\u65bc\u662f\u4ed6\u5c31\u6c7a\u5b9a\u505a\u4e00\u500b\u5be6\u9a57\uff0c\u4e0d\u770b\u91ab\u751f\u4e5f\u4e0d\u5403\u85e5\uff0c\u7d50\u679c\u5728\u5169\u500b\u661f\u671f\u5f8c\uff0c\u771f\u7684\u81ea\u7136\u597d\u4e86\uff0c\u6240\u6709\u6d41\u9f3b\u6d95\u3001\u54b3\u55fd\u53ca\u767c\u71d2\u7684\u75c7\u72c0\u90fd\u6d88\u5931\u3002\u6709\u95dc\u9019\u6bb5\u6642\u9593\u4e2d\u963f\u5409\u9ad4\u5167\u7684\u514d\u75ab\u53cd\u61c9\u4e4b\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u5728\u75c5\u6bd2\u611f\u67d3\u7684\u5e7e\u500b\u5c0f\u6642\u5167\uff0c\u963f\u5409\u7684\u80ba\u90e8\u6703\u6709\u5927\u91cf\u7684\u7d30\u80de\u6fc0\u7d20\uff08cytokines\uff09\uff0c\u5305\u542b\u7b2c\u4e00\u53ca\u7b2c\u4e09\u578b\u5e72\u64fe\u7d20\uff08interferons\uff09\u7684\u7522\u751f\uff0c\u4e26\u4e14\u8b93\u80ba\u90e8\u7684\u7d30\u80de\u9032\u5165\u6297\u75c5\u6bd2\u72c0\u614b", "B": "\u5728\u75c5\u6bd2\u611f\u67d3\u7684\u5e7e\u500b\u5c0f\u6642\u5230\u5e7e\u5929\u5167\uff0c\u963f\u5409\u80ba\u90e8\u7684\u81ea\u7136\u6bba\u624b\u7d30\u80de\uff08natural killer cell, NK cell\uff09\u6703\u958b\u59cb\u4f5c\u7528\uff0c\u6bba\u6b7b\u88ab\u75c5\u6bd2\u611f\u67d3\u7684\u7d30\u80de", "C": "\u5728\u75c5\u6bd2\u611f\u67d3\u7684\u5e7e\u5929\u5f8c\uff0cCD8 T\u7d30\u80de\u6703\u5728\u6dcb\u5df4\u7d50\u4e2d\u88ab\u6d3b\u5316\u4e26\u9032\u884c\u6297\u9ad4\u4f9d\u8cf4\u6027\u7684\u7d30\u80de\u6bd2\u6bba\u4f5c\u7528\uff08ADCC\uff09\uff0c\u9032\u4e00\u6b65\u6bba\u6b7b\u88ab\u75c5\u6bd2\u611f\u67d3\u7684\u7d30\u80de\uff0c\u4e26\u6e05\u9664\u75c5\u6bd2", "D": "\u5728\u75c5\u6bd2\u611f\u67d3\u7684\u5e7e\u5929\u5f8c\uff0cB\u7d30\u80de\u6703\u88ab\u6d3b\u5316\uff0c\u4e26\u9032\u4e00\u6b65\u5206\u5316\u6210\u6f3f\u7d30\u80de\uff08plasma cell\uff09\u800c\u5206\u6ccc\u6297\u9ad4\uff0c\u6297\u9ad4\u53ef\u4ee5\u7d93\u7531\u8840\u6db2\u5faa\u74b0\u53bb\u4e2d\u548c\u75c5\u6bd2\u4f86\u9632\u6b62\u75c5\u6bd2\u64f4\u6563\u5230\u5168\u8eab", "answer": "3"}, {"year": "110-1-2", "id": "12988", "type": "\u514d\u75ab\u5b78", "question": "\u4e0b\u5217\u4f55\u7a2e\u88dc\u9ad4\u8abf\u63a7\u86cb\u767d\uff08complement-regulatory proteins\uff09\u662f\u76f4\u63a5\u5e72\u64feC9\u7684\u805a\u5408\u5316\u4ee5\u6291\u5236\u819c\u653b\u64ca\u8907\u5408\u7269\uff08membrane attack complex, MAC\uff09\u7684\u5f62\u6210\uff1f", "qimg": "0", "A": "CD59", "B": "membrane cofactor of proteolysis\uff08MCP, CD46\uff09", "C": "decay-accelerating factor\uff08DAF, CD55\uff09", "D": "C1 inhibitor", "answer": "1"}, {"year": "110-1-2", "id": "12989", "type": "\u514d\u75ab\u5b78", "question": "\u5927\u90e8\u5206\u7684\u5c08\u696d\u6027\u541e\u566c\u7d30\u80de\u4e5f\u540c\u6642\u53ef\u57f7\u884c\u5c08\u696d\u6027\u6297\u539f\u5448\u737b\u7d30\u80de\uff08antigen-presenting cells\uff09\u7684\u529f\u80fd\uff0c\u5c07\u6297\u539f\u5448\u737b\u7d66CD4 T\u7d30\u80de\u3002\u5176\u4e3b\u8981\u7684\u539f\u56e0\u662f\u9019\u7fa4\u5c08\u696d\u6027\u6297\u539f\u5448\u737b\u7d30\u80de\u5927\u91cf\u8868\u73fe\uff1a", "qimg": "0", "A": "MHC class I\u5206\u5b50", "B": "MHC class II\u5206\u5b50", "C": "MHC class III\u5206\u5b50", "D": "pattern recognition receptors", "answer": "2"}, {"year": "110-1-2", "id": "12990", "type": "\u514d\u75ab\u5b78", "question": "\u6297\u9ad4\u591a\u6a23\u6027\uff08antibody diversity\uff09\u7684\u6a5f\u5236\u662f\u6297\u9ad4\u53ef\u8fa8\u8b58\u5404\u5f0f\u5404\u6a23\u6297\u539f\u7684\u4e3b\u8981\u539f\u56e0\uff0c\u6709\u95dc\u6297\u9ad4\u591a\u6a23\u6027\u7684\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "Susumu Tonegawa\u6559\u6388\u56e0\u767c\u73fe\u6297\u9ad4\u591a\u6a23\u6027\u7684\u907a\u50b3\u53ca\u5206\u5b50\u4f5c\u7528\u539f\u7406\u7372\u5f97\u8afe\u8c9d\u723e\u91ab\u5b78\u734e", "B": "\u6297\u9ad4\u591a\u6a23\u6027\u662f\u5728B\u7d30\u80de\u7684\u767c\u80b2\u904e\u7a0b\u6240\u7522\u751f\u7684\u7d50\u679c", "C": "\u5728B\u7d30\u80de\u767c\u80b2\u904e\u7a0b\u6240\u9020\u6210\u7684\u6297\u9ad4\u591a\u6a23\u6027\u5305\u542b\u7d44\u5408\u591a\u6a23\u6027\uff08combinatorial diversity\uff09\u53ca\u9023\u63a5\u591a\u6a23\u6027\uff08junctionaldiversity\uff09", "D": "\u7576\u6d3b\u5316\u7684B\u7d30\u80de\u9032\u884c\u6297\u9ad4\u8f49\u63db\uff08isotype switching\uff09\u6642\u4e5f\u6703\u8ca2\u737b\u6297\u9ad4\u591a\u6a23\u6027", "answer": "4"}, {"year": "110-1-2", "id": "12991", "type": "\u514d\u75ab\u5b78", "question": "2018\u5e74\u8afe\u8c9d\u723e\u91ab\u5b78\u734e\u9812\u767c\u7d662\u4f4d\u5c0d\u764c\u75c7\u514d\u75ab\u7642\u6cd5\u6709\u91cd\u5927\u8ca2\u737b\u7684\u79d1\u5b78\u5bb6\uff0cJames P. Allison\u8207Tasuku Honjo\u56e0\u958b\u767cCTLA-4\u8207PD-1\u5728\u764c\u75c7\u6cbb\u7642\u7684\u61c9\u7528\u800c\u7372\u734e\u3002\u4e0b\u5217\u6709\u95dc\u514d\u75ab\u7cfb\u7d71\u548c\u816b\u7624\u7d30\u80de\u4ea4\u4e92\u4f5c\u7528\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u816b\u7624\u7d30\u80de\u5982\u679c\u8868\u73fe\u816b\u7624\u7279\u5b9a\u6297\u539f\uff0c\u53ef\u4ee5\u5f15\u767c\u5c08\u4e00\u6027\u7684\u6bd2\u6bba\u6027T\u7d30\u80de\uff08cytotoxic T cells\uff09\u4f86\u6e05\u9664\u816b\u7624", "B": "\u816b\u7624\u7d30\u80de\u5982\u679c\u7d2f\u7a4d\u7a81\u8b8a\uff0c\u53ef\u4ee5\u8868\u73feCTLA-4\u5728\u5176\u7d30\u80de\u8868\u9762\uff0c\u56e0\u6b64\u6291\u5236T\u7d30\u80de\u7684\u53cd\u61c9", "C": "\u9664\u4e86\u6bd2\u6bba\u6027T\u7d30\u80de\uff08cytotoxic T cells\uff09\u4e4b\u5916\uff0c\u81ea\u7136\u6bba\u624b\u7d30\u80de\uff08natural killer cells\uff09\u4e5f\u6703\u6e05\u9664\u816b\u7624", "D": "\u8b93\u764c\u75c7\u75c5\u4eba\u65bd\u6253\u5c0d\u6297CTLA-4\u6216PD-1\u7684\u6297\u9ad4\u662f\u4e00\u7a2e\u764c\u75c7\u7684\u514d\u75ab\u7642\u6cd5\uff0c\u53ef\u4ee5\u963b\u65b7\u6291\u5236\u8a0a\u865f\uff0c\u9032\u800c\u6d3b\u5316T\u7d30\u80de\u4f86\u6e05\u9664\u816b\u7624", "answer": "2"}, {"year": "110-1-2", "id": "12992", "type": "\u514d\u75ab\u5b78", "question": "\u4e0d\u540c\u7684\u6297\u9ad4\u985e\u578b\uff08class \u6216\u7a31 isotype\uff09\u5177\u6709\u4e0d\u540c\u529f\u80fd\u662f\u56e0\u70ba\u6297\u9ad4\u7684Fc\u80fd\u5920\u85c9\u7531\u8207Fc\u53d7\u9ad4\uff08Fc receptor\uff09\u7684\u7d50\u5408\u53bb\u555f\u52d5\u4e0d\u540c\u514d\u75ab\u7d30\u80de\u7684\u53cd\u61c9\uff0c\u4e0b\u5217\u6709\u95dcFc\u53d7\u9ad4\u7684\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "Fc\u53d7\u9ad4\u53ef\u4ee5\u662f\u55ae\u9ad4\uff08monounit\uff09\u6216\u662f\u4ee5\u8907\u5408\u9ad4\uff08multisubunit complex\uff09\u7684\u5f62\u5f0f\u5b58\u5728\u7d30\u80de\u8868\u9762", "B": "\u4e0d\u540c\u4e9e\u578b\uff08subclasses\uff09\u7684\u6297\u9ad4\u53ef\u4ee5\u548c\u540c\u4e00\u7a2e\u7684Fc\u53d7\u9ad4\u7d50\u5408\uff0c\u800c\u4e14\u5b83\u5011\u548cFc\u53d7\u9ad4\u7684\u89aa\u5408\u529b\u4e5f\u90fd\u4e00\u6a23", "C": "\u8655\u65bc\u81ea\u7531\u72c0\u614b\u7684\u6297\u9ad4\uff08free antibody\uff09\u53ef\u4ee5\u548cFc\u53d7\u9ad4\u7d50\u5408\uff0c\u7d93\u6297\u539f\u7d50\u5408\u5f8c\u7684\u6297\u9ad4\u6703\u50b3\u905e\u8a0a\u865f\u53bb\u6d3b\u5316\u6216\u6291\u5236\u8868\u73feFc\u53d7\u9ad4\u7684\u514d\u75ab\u7d30\u80de\u7684\u529f\u80fd", "D": "\u5927\u90e8\u5206\u8868\u73feFc\u53d7\u9ad4\u90fd\u662f\u5177\u6709\u541e\u566c\u80fd\u529b\u7684\u7d30\u80de\u5982\u5de8\u566c\u7d30\u80de\u548c\u55dc\u4e2d\u6027\u7403\uff0c\u800c\u4e14\u7576\u7d30\u83cc\u540c\u6642\u88ab\u6297\u9ad4\u548c\u88dc\u9ad4\u7d50\u5408\u5f8c\uff0c\u541e\u566c\u7d30\u80de\u7684Fc\u53d7\u9ad4\u548c\u88dc\u9ad4\u53d7\u9ad4CR1\u7684\u540c\u6642\u4f5c\u7528\u6703\u5f15\u767c\u66f4\u5f37\u70c8\u7684\u541e\u566c\u53cd\u61c9", "answer": "2"}, {"year": "110-1-2", "id": "12993", "type": "\u514d\u75ab\u5b78", "question": "\u9ecf\u819c\uff08mucosa\uff09\u7d44\u7e54\u5c0d\u98df\u7269\u6297\u539f\u4f8b\u5982\u9ea9\u8cea\u86cb\u767d\uff08gluten\uff09\u6240\u7522\u751f\u7684\u6297\u9ad4\u4e3b\u8981\u7a2e\u985e\u70ba\uff1a", "qimg": "0", "A": "IgG", "B": "IgA", "C": "IgM", "D": "IgD", "answer": "2"}, {"year": "110-1-2", "id": "12994", "type": "\u514d\u75ab\u5b78", "question": "\u4e0b\u5217\u4f55\u7a2e\u4f5c\u7528\u6700\u9069\u5408\u63cf\u8ff0\u7d50\u6838\u687f\u83cc\uff08Mycobacterium tuberculosis\uff09\u7684\u514d\u75ab\u9003\u812b\uff08immune evasion\uff09\u6a5f\u5236\uff1f", "qimg": "0", "A": "antigenic drift\uff08gene mutation\uff09", "B": "gene conversion\uff08gene rearrangement\uff09", "C": "\u963b\u65b7MHC class I pathway", "D": "\u6291\u5236\u541e\u566c\u9ad4\uff08phagosome\uff09\u8207\u6eb6\u9176\u9ad4\uff08lysosome\uff09\u7684\u878d\u5408", "answer": "4"}, {"year": "110-1-2", "id": "12995", "type": "\u514d\u75ab\u5b78", "question": "\u6709\u95dctumor immunoediting\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u514d\u75ab\u76e3\u6e2c\u7cfb\u7d71\u6703\u5c0e\u81f4\u816b\u7624\u7d30\u80de\u7522\u751f\u7a81\u8b8a", "B": "\u514d\u75ab\u76e3\u6e2c\u7cfb\u7d71\u6703\u5c0e\u81f4\u816b\u7624\u7d30\u80de\u7522\u751f\u7684\u6297\u539f\u8868\u73fe\u6d88\u5931", "C": "\u514d\u75ab\u76e3\u6e2c\u7cfb\u7d71\u6703\u5c0e\u81f4\u816b\u7624\u7d30\u80de\u7522\u751f\u7684\u7d30\u80de\u7279\u6027\u6539\u8b8a", "D": "\u4fc3\u9032T\u7d30\u80de\u5c0d\u816b\u7624\u7d30\u80de\u7684\u6bd2\u6bba\u80fd\u529b\uff0c\u5c0e\u81f4\u816b\u7624\u7e2e\u5c0f", "answer": "4"}, {"year": "110-1-2", "id": "12996", "type": "\u514d\u75ab\u5b78", "question": "\u7576\u75c5\u4eba\u63a5\u53d7\u814e\u81df\u79fb\u690d\u5f8c10\u5206\u9418\u5167\u5c31\u767c\u751f\u6392\u65a5\uff0c\u5176\u4e3b\u8981\u539f\u56e0\u662f\uff1a", "qimg": "0", "A": "MHC class I\u4e0d\u5408", "B": "MHC class II\u4e0d\u5408", "C": "\u75c5\u4eba\u9ad4\u5167\u5df2\u5b58\u6709\u5c0d\u6297\u79fb\u690d\u7269\u7684\u6297\u9ad4", "D": "H\u6297\u539f\u4e0d\u5408", "answer": "3"}, {"year": "110-1-2", "id": "12997", "type": "\u514d\u75ab\u5b78", "question": "\u7528\u4f86\u6cbb\u7642non-Hodgkin\u2019s lymphoma\u7684Rituximab\uff08anti-CD20 monoclonal antibody\uff09\u4e3b\u8981\u53ef\u4ee5\u5254\u9664\u4f55\u7a2e\u514d\u75ab\u7d30\u80de\uff1f", "qimg": "0", "A": "CD4 T cell", "B": "CD8 T cell", "C": "B cell", "D": "dendritic cell", "answer": "3"}, {"year": "110-1-2", "id": "12998", "type": "\u5bc4\u751f\u87f2\u5b78", "question": "\u5f35\u5148\u751f\u55dc\u5403\u751f\u9b5a\u7247\uff0c\u6700\u8fd1\u5e38\u51fa\u73fe\u8179\u90e8\u7d5e\u75db\u3001\u8179\u9cf4\uff08borborygmus\uff09\u3001\u8179\u7009\u3001\u53ad\u98df\u3001\u5641\u5fc3\u3001\u5614\u5410\u53ca\u4f4e\u8840\u58d3\u7b49\u75c7\u72c0\uff0c\u4e26\u4f34\u96a8\u6709\u4f4e\u86cb\u767d\u8840\u75c7\u3001\u4f4e\u8840\u9240\u53ca\u4f4e\u8840\u9223\u7b49\u56b4\u91cd\u96fb\u89e3\u8cea\u5931\u8861\u75c5\u75c7\uff0c\u5f35\u5148\u751f\u6700\u6709\u53ef\u80fd\u611f\u67d3\u4e0b\u5217\u4f55\u7a2e\u5bc4\u751f\u87f2\uff1f", "qimg": "0", "A": "\u83f2\uf9d8\u8cd3\u6bdb\u7dda\u87f2\uff08Capillaria philippinensis\uff09", "B": "\u6d77\u7378\u80c3\u7dda\u87f2\uff08Anisakis spp.\uff09", "C": "\u65cb\u6bdb\u87f2\uff08Trichinella spiralis\uff09", "D": "\u6709\u68d8\u981c\u53e3\u7dda\u87f2\uff08Gnathostoma spinigerum\uff09", "answer": "1"}, {"year": "110-1-2", "id": "12999", "type": "\u5bc4\u751f\u87f2\u5b78", "question": "\u95dc\u65bc\u5ee3\u6771\u4f4f\u8840\u7dda\u87f2\uff08Angiostrongylus cantonensis\uff09\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u611f\u67d3\u4eba\u9ad4\u6703\u5f15\u8d77\u55dc\u4f0a\u7d05\u6027\u8166\u819c\u708e\uff08eosinophilic meningitis\uff09", "B": "\u78ba\u8a8d\u8a3a\u65b7\u662f\u5728\u8166\u810a\u9ad3\u6db2\u4e2d\u767c\u73fe\u87f2\u9ad4", "C": "\u5403\u751f\u83dc\u6c99\u62c9\u4e0d\u6703\u611f\u67d3", "D": "\u60a3\u8005\u8166\u810a\u9ad3\u6db2\u4e2d\u55dc\u9178\u6027\u767d\u8840\u7403\uff08eosinophil\uff09\uf962\u5e38\u589e\u52a0", "answer": "3"}, {"year": "110-1-2", "id": "13000", "type": "\u5bc4\u751f\u87f2\u5b78", "question": "\u6709\u95dc\u4eba\u985e\u611f\u67d3\u9846\u7c92\u6027\u5305\u751f\u7d5b\u87f2\uff08Echinococcus granulosus\uff09\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba \uff1f", "qimg": "0", "A": "\u4eba\u985e\u4fc2\u98df\u5165\u751f\u7684\u6216\u672a\u716e\u719f\u7684\u7f8a\u8089\u800c\u611f\u67d3", "B": "\u6703\u5728\u60a3\u8005\u809d\u81df\u5f62\u6210\u5305\u751f\u56ca\uff08hydatid cyst\uff09", "C": "\u75c5\u7076\u5340\u5207\u9762\u5448\u73fe\u80ba\u6ce1\u72c0\u56ca\uff08alveolar cyst\uff09\uff0c\u4e26\u6709\u8a31\u591a\u7a7a\u8154", "D": "\u53ef\u5728\u60a3\u8005\u7cde\u4fbf\u4e2d\u6aa2\u51fa\u516d\u9264\u5e7c\u87f2\uff08oncosphere\uff09\u5375", "answer": "2"}, {"year": "110-1-2", "id": "13001", "type": "\u5bc4\u751f\u87f2\u5b78", "question": "\u4e0b\u5217\u4f55\u7a2e\u5bc4\u751f\u87f2\u611f\u67d3\uff0c \u4e0d\u53ef\u80fd\u5728\u4eba\u985e\u8166\u90e8\u9020\u6210\u7570\u4f4d\u75c5\u8b8a\uff08ectopic lesion\uff09\uff0c\u5f15\u8d77\u56b4\u91cd\u7684\u81e8\u5e8a\u75c7\u72c0\uff1f", "qimg": "0", "A": "\u65e5\u672c\u8840\u5438\u87f2\uff08Schistosoma japonicum\uff09", "B": "\u885b\u6c0f\u80ba\u5438\u87f2\uff08Paragonimus westermani\uff09", "C": "\u8591\u7247\u87f2\uff08Fasciolopsis buski\uff09", "D": "\uf962\u5f62\uf962\u5f62\u5438\u87f2\uff08Heterophyes heterophyes\uff09", "answer": "3"}, {"year": "110-1-2", "id": "13002", "type": "\u5bc4\u751f\u87f2\u5b78", "question": "\u6709\u95dc\u7f79\u60a3\u7627\u75be\uff08malaria\uff09\u5f8c\u7522\u751f\u4f75\u767c\u75c7\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u814e\u7d72\u7403\u6027\u814e\u708e\uff08glomerulonephritis\uff09\uff1a\u4fc2\u56e0\u4e09\u65e5\u7627\u539f\u87f2\uff08Plasmodium malariae\uff09\u611f\u67d3\u5f8c\uff0c\u904e\u591a\u7684\u539f\u87f2\u6c89\u7a4d\u5728\u814e\u7d72\u7403\u6240\u9020\u6210\u7684\u75c5\u8b8a", "B": "\u9ed1\u6c34\u71b1\uff08blackwater fever\uff09\uff1a\u548c\u81ea\u9ad4\u514d\u75ab\u6709\u95dc\uff0c\u60a3\u8005\u7522\u751f\u6297\u9ad4\u653b\u64ca\u53d7\u7627\u539f\u87f2\u611f\u67d3\u7684\u7d05\u8840\u7403\uff0c\u5c0e\u81f4\u7834\u88c2\u800c\u9020\u6210", "C": "\u71b1\u5e36\u813e\u816b\u5927\u75c7\u5019\u7fa4\uff08tropical splenomegaly syndrome\uff09\uff1a\u60a3\u8005\u9ad4\u5167 T \u6dcb\u5df4\u7403\u7684\u5927\u91cf\u589e\u751f\u6240\u81f4", "D": "\u4f4e\u8840\u7cd6\u75c7\uff08hypoglycemia\uff09\uff1a\u7279\u5225\u662f\u5728\u60e1\u6027\u7627\u539f\u87f2\uff08Plasmodium falciparum\uff09\u767c\u4f5c\u6642\uff0c\u8840\u58d3\u5feb\u901f\u964d\u4f4e\u4e26\u4f34\u96a8\u9ad8\u5bc4\u751f\u87f2\u8840\u75c7\uff08hyperparasitemia\uff09\u6709\u95dc", "answer": "2"}, {"year": "110-1-2", "id": "13003", "type": "\u5bc4\u751f\u87f2\u5b78", "question": "\u4eba\u985e\u56e0\u8aa4\u98df\u53d7\u611f\u67d3\u4e4b\u8c93\uff08\u72d7\uff09\u86a4\uff08flea\uff09\uff0c \u53ef\u80fd\u611f\u67d3\u4e0b\u5217\u4f55\u7a2e\u5bc4\u751f\u87f2\uff1f", "qimg": "0", "A": "\u72ac\u86d4\u87f2\uff08Toxocara canis\uff09", "B": "\u72ac\u8907\u6b96\u5668\u7d5b\u87f2\uff08Dipylidium caninum\uff09", "C": "\u72ac\u9264\u87f2\uff08Ancylostoma caninum\uff09", "D": "\u83f2\u5f8b\u8cd3\u6bdb\u7dda\u87f2\uff08Capillaria philippinensis\uff09", "answer": "2"}, {"year": "110-1-2", "id": "13004", "type": "\u5bc4\u751f\u87f2\u5b78", "question": "\u91c7\u91c7\u8805\uff08tsetse fly\uff09\u53ef\u7d93\u53ee\u54ac\u800c\u50b3\u64ad\u4e0b\u5217\u4f55\u7a2e\u4eba\u985e\u5bc4\u751f\u87f2\uff1f", "qimg": "0", "A": "\u71b1\u5e36\u5229\u4ec0\u66fc\u539f\u87f2\uff08Leishmania tropica\uff09", "B": "\u675c\u6c0f\u5229\u4ec0\u66fc\u539f\u87f2\uff08Leishmania donovani\uff09", "C": "\u5ca1\u6bd4\u4e9e\u9310\u87f2\uff08Trypanosoma brucei gambiense\uff09", "D": "\u67af\u897f\u6c0f\u9310\u87f2\uff08Trypanosoma cruzi\uff09", "answer": "3"}, {"year": "110-1-2", "id": "13005", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u76f8\u8f03\u65bc\u4e16\u4ee3\u8ffd\u8e64\u7814\u7a76\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u75c5\u4f8b\u5c0d\u7167\u7814\u7a76\u7684\u7f3a\u9ede\uff1f", "qimg": "0", "A": "\u5bb9\u6613\u7522\u751f\u9078\u64c7\u6027\u504f\u5dee", "B": "\u9700\u8981\u66f4\u9577\u7814\u7a76\u6642\u9593", "C": "\u9700\u8981\u66f4\u591a\u6a23\u672c\u6578", "D": "\u7121\u6cd5\u63a2\u8a0e\u591a\u91cd\u75c5\u56e0", "answer": "1"}, {"year": "110-1-2", "id": "13006", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u5982\u679c\u60f3\u8981\u6bd4\u8f03\u5e74\u8f15\u4eba\u8207\u8001\u5e74\u4eba\u7684\u6d41\u611f\u7f79\u60a3\u7387\uff0c\u738b\u91ab\u5e2b\u96a8\u6a5f\u6536\u96c6100\u4f4d\u5e74\u8f15\u4eba\u8207100\u4f4d\u8001\u5e74\u4eba\u6c11\u773e\uff0c\u8a62\u554f\u5176\u904e\u53bb\u4e00\u500b\u6708\u662f\u5426\u7f79\u60a3\u6d41\u611f\uff0c\u5176\u4e2d\u670942\u4f4d\u5e74\u8f15\u4eba\u53ca22\u4f4d\u8001\u5e74\u4eba\u56de\u7b54\u6709\uff0c\u56e0\u6b64\u4f30\u8a08\u5e74\u8f15\u4eba\u6d41\u611f\u7f79\u60a3\u7387\u70ba0.42\uff0c\u8001\u5e74\u4eba\u6d41\u611f\u7f79\u60a3\u7387\u70ba0.22\u3002\u4e0b\u5217\u4f55\u8005\u6700\u4e0d\u6070\u7576\uff1f", "qimg": "0", "A": "\u738b\u91ab\u5e2b\u7684\u96a8\u6a5f\u62bd\u6a23\u5fc5\u9808\u6392\u9664\u6709\u53ef\u80fd\u4e92\u76f8\u50b3\u67d3\u7684\u6a23\u672c\uff0c\u624d\u80fd\u5f97\u5230\u9019\u4e9b\u4f30\u8a08\u503c", "B": "\u738b\u91ab\u5e2b\u7684\u4f30\u8a08\u503c0.42\uff0c\u5fc5\u9808\u5047\u8a2d\u6bcf\u500b\u5e74\u8f15\u4eba\u5f97\u6d41\u611f\u7684\u6a5f\u7387\u90fd\u662f\u4e00\u6a23\u4e14\u4e92\u76f8\u7368\u7acb\uff0c\u624d\u80fd\u6210\u7acb", "C": "\u738b\u91ab\u5e2b\u7684\u8001\u5e74\u4eba\u6a23\u672c\u5982\u679c\u6e90\u81ea1000\u5e8a\u7684\u8001\u4eba\u5b89\u990a\u4e2d\u5fc3\u7684\u96a8\u6a5f\u62bd\u6a23\uff0c\u5247\u53ef\u80fd\u56e0\u70ba\u7fa4\u805a\u6548\u61c9\uff0c\u4e0d\u5b9c\u8996\u70ba\u7368\u7acb\u6a23\u672c", "D": "\u738b\u91ab\u5e2b\u53ef\u4ee5\u5408\u4f75\u6a23\u672c\uff0c\u5229\u7528200\u4eba\u7576\u4e2d\u670942+22=64\u4f4d\u5f97\u5230\u6d41\u611f\uff0c\u4f86\u4f30\u8a08\u4eba\u53e3\u4e2d\u5f97\u6d41\u611f\u7684\u6a5f\u7387\u70ba0.32", "answer": "4"}, {"year": "110-1-2", "id": "13007", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "A\u3001B\u3001C\u3001D\u56db\u6821\u5b78\u751f\u667a\u5546\u91cf\u8868\u6e2c\u9a57\u5206\u6578\u5e73\u5747\u503c\u4e4b 95% \u4fe1\u8cf4\u5340\u9593\u5206\u5225\u70ba\uff0cA\u6821\uff1a94~98 \u5206\uff1bB\u6821\uff1a98~106\u5206\uff1bC\u6821\uff1a100~106 \u5206\uff1bD\u6821\uff1a104~108 \u5206\u3002\u82e5\u7d71\u8a08\u986f\u8457\u6c34\u6e96\u70ba 0.05\uff0c\u5247\u4e0b\u5217\u90a3\u5169\u500b\u5b78\u6821\u4e4b\u9593\u7684\u667a\u5546\u5206\u6578\u5177\u6709\u986f\u8457\u5dee\u7570\uff1f", "qimg": "0", "A": "A\u6821\u8207B\u6821", "B": "A\u6821\u8207C\u6821", "C": "B\u6821\u8207D\u6821", "D": "C\u6821\u8207D\u6821", "answer": "2"}, {"year": "110-1-2", "id": "13008", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u95dc\u65bc\u5168\u7403\u6696\u5316\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6700\u4e0d\u6070\u7576\uff1f", "qimg": "0", "A": "\u5728\u5404\u7a2e\u6eab\u5ba4\u6c23\u9ad4\u4e2d\uff0c\u9664\u6c34\u84b8\u6c23\u5916\u4ee5\u4e8c\u6c27\u5316\u78b3\uff08CO2\uff09\u70ba \u91cd\u8981", "B": "\u61f8\u6d6e\u5fae\u7c92\u5c0d\u6c23\u6eab\u7684\u5f71\u97ff\u8207CO2\u5c0d\u6c23\u6eab\u7684\u5f71\u97ff\u4e00\u81f4\uff0c\u4e26\u6709\u76f8\u4e92\u52a0\u6210\u4f5c\u7528", "C": "\u5168\u7403\u6696\u5316\u5c0d\u5065\u5eb7\u7684\u5a01\u8105\u662f\u5168\u7403\u74b0\u5883\u8b8a\u9077\u7684\u91cd\u8981\u8b70\u984c", "D": "\u4eac\u90fd\u8b70\u5b9a\u66f8\uff08Kyoto Protocol\uff09\u4e3b\u8981\u5b97\u65e8\u70ba\u524a\u6e1b\u6eab\u5ba4\u6c23\u9ad4\u6392\u653e\u91cf", "answer": "2"}, {"year": "110-1-2", "id": "13009", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u4e0b\u5217\u6709\u95dc\u65bc\u7837\u66b4\u9732\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u6700\u4e0d\u6070\u7576\uff1f", "qimg": "0", "A": "\u81fa\u7063\u897f\u5357\u6cbf\u6d77\u66fe\u767c\u751f\u70cf\u8173\u75c5\u7684\u6d41\u884c\uff0c\u5176\u539f\u56e0\u53ef\u80fd\u8207\u5730\u6cb3\u4e95\u6c34\u542b\u7837\u6709\u95dc", "B": "\u7837\u66b4\u9732\u4e5f\u53ef\u80fd\u6709\u8f03\u9ad8\u98a8\u96aa\u7f79\u60a3\u8180\u80f1\u764c\u3001\u809d\u764c\u3001\u80ba\u764c\u53ca\u814e\u764c", "C": "\u4eba\u6216\u52d5\u7269\u7684\u6bdb\u9aee\u6216\u6307\u7532\u53ef\u4f5c\u70ba\u5206\u6790\u74b0\u5883\u66b4\u9732\u7a0b\u5ea6\u7684\u5de5\u5177", "D": "\u81fa\u7063\u81ea\u5f9e\u63d0\u4f9b\u81ea\u4f86\u6c34\u5f8c\uff0c\u7837\u66b4\u9732\u7684\u98a8\u96aa\u5373\u660e\u986f\u4e0b\u964d", "answer": "1234"}, {"year": "110-1-2", "id": "13010", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u5728\u9580\u8a3a\u4e2d\u770b\u5230\u75c5\u4eba\u60a3\u6709\u809d\u8840\u7ba1\u8089\u7624\uff0c \u53ef\u80fd\u7684\u8077\u696d\u66b4\u9732\u70ba\u4f55\uff1f", "qimg": "0", "A": "\u9ecf\u6263\u5e36\u4e2d\u7684\u4e8c\u7570\u6c30\u9178\u7532\u82ef\u66b4\u9732", "B": "\u9333\u9435\u7194\u7149\u66b4\u9732", "C": "\u77f3\u5316\u5de5\u5ee0\u6c2f\u4e59\u70ef\u66b4\u9732", "D": "\u925b\u84c4\u96fb\u6c60\u56de\u6536\u66b4\u9732", "answer": "3"}, {"year": "110-1-2", "id": "13011", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u8077\u696d\u885b\u751f\u4e2d8\u5c0f\u6642\u65e5\u6642\u91cf\u5e73\u5747\u5bb9\u8a31\u6fc3\u5ea6\uff0c\u662f\u6307\u8a72\u6fc3\u5ea6\uff0c\u5728\u4e0b\u5217\u4f55\u7a2e\u60c5\u6cc1\u5927\u90e8\u5206\u7684\u5de5\u4f5c\u4eba\u54e1\uff0c\u7d42\u5176\u4e00\u751f\u4e0d\u6703\u767c\u751f\u4e0d\u826f\u5065\u5eb7\u6548\u61c9\u7684\u6fc3\u5ea6\uff1f", "qimg": "0", "A": "\u6bcf\u9031\u5de5\u4f5c48\u5c0f\u6642\uff0c\u6bcf\u9031\u5de5\u4f5c6\u5929", "B": "\u6bcf\u9031\u5de5\u4f5c44\u5c0f\u6642\uff0c\u6bcf\u9031\u5de5\u4f5c5\u5929", "C": "\u6bcf\u9031\u5de5\u4f5c40\u5c0f\u6642\uff0c\u6bcf\u9031\u5de5\u4f5c5\u5929", "D": "\u6bcf\u9031\u5de5\u4f5c42\u5c0f\u6642\uff0c\u6bcf\u9031\u5de5\u4f5c5\u5929", "answer": "3"}, {"year": "110-1-2", "id": "13012", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u6709\u95dc\u5065\u5eb7\u57ce\u5e02\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6700\u4e0d\u6070\u7576\uff1f", "qimg": "0", "A": "\u5065\u5eb7\u57ce\u5e02\u662f\u4e00\u7a2e\u7d50\u679c\uff0c\u8207\u904e\u7a0b\u7121\u95dc", "B": "\u5065\u5eb7\u57ce\u5e02\u7684\u884c\u52d5\u65b9\u6848\u662f\u6839\u64da\u57ce\u5e02\u81ea\u5df1\u7684\u512a\u5148\u6b21\u5e8f", "C": "\u57ce\u5e02\u53ca\u9109\u93ae\u9593\u80fd\u76f8\u4e92\u652f\u6301\u3001\u5408\u4f5c\u3001\u5b78\u7fd2\u53ca\u6587\u5316\u4ea4\u6d41", "D": "\u5065\u5eb7\u57ce\u5e02\u95dc\u5fc3\u4e16\u754c\u8cc7\u6e90\u516c\u5e73\u5206\u914d", "answer": "1"}, {"year": "110-1-2", "id": "13013", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u67d0\u8077\u5834\u96c7\u4e3b\u57fa\u65bc\u4e0a\u73ed\u65cf\u7d93\u5e38\u5750\u5728\u8fa6\u516c\u5ba4\u5de5\u4f5c\uff0c\u56e0\u6b64\u60f3\u63a8\u52d5\u8077\u5834\u5065\u5eb7\u4fc3\u9032\u8a08\u756b\uff0c\u4eba\u8cc7\u90e8\u5c31\u5148\u53bb\u8abf\u67e5\u8077\u5834\u54e1\u5de5\u7684\u904b\u52d5\u7fd2\u6163\uff0c\u767c\u73fe I.\u5927\u90e8\u5206\u54e1\u5de5\u90fd\u6709\u60f3\u904b\u52d5\u53ea\u662f\u5c1a\u672a\u884c\u52d5\u3001II.\u5c11\u6578\u54e1\u5de5\u5df2\u7d93\u958b\u59cb\u8cb7\u4e86\u904b\u52d5\u5668\u6750\uff0c\u4f46\u5c1a\u672a\u898f\u5f8b\u9032\u884c\u904b\u52d5\u3002\u4ee5\u4e0a\u6558\u8ff0I.\u8207II.\uff0c\u5404\u6307\u7684\u662f\u54e1\u5de5\u90a3\u4e00\u500b\u884c\u70ba\u6539\u8b8a\u968e\u6bb5\uff1f", "qimg": "0", "A": "I.\u61f5\u61c2\u671f\uff08pre-contemplation phase\uff09\u3001II.\u6e96\u5099\u671f\uff08preparation phase\uff09", "B": "I.\u6e96\u5099\u671f\uff08preparation phase\uff09\u3001II.\u884c\u52d5\u671f\uff08action phase\uff09", "C": "I.\u6c89\u601d\u671f\uff08contemplation phase\uff09\u3001II.\u6e96\u5099\u671f\uff08preparation phase\uff09", "D": "I.\u6c89\u601d\u671f\uff08contemplation phase\uff09\u3001II.\u884c\u52d5\u671f\uff08action phase\uff09", "answer": "3"}, {"year": "110-1-2", "id": "13014", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u6709\u95dc\u975e\u6cd5\u85e5\u7269\uff08\u6bd2\u54c1\uff09\u9632\u5236\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6700\u4e0d\u6070\u7576\uff1f", "qimg": "0", "A": "\u6839\u64da \u65b0\u6bd2\u54c1\u5371\u5bb3\u9632\u5236\u689d\u4f8b\u5c0d\u6bd2\u54c1\u7684\u5206\u7d1a\uff0cK\u4ed6\u547d\u70ba\u7b2c\u4e09\u7d1a", "B": "\u6bd4\u8d77\u6027\u683c\u8f03\u5167\u5411\u4fdd\u5b88\uff0c\u5916\u5411\u4e14\u504f\u597d\u8ffd\u6c42\u523a\u6fc0\u8207\u65b0\u5947\u4e8b\u7269\u7684\u9752\u5c11\u5e74\u5728\u63a5\u89f8\u6216\u5617\u8a66\u6bd2\u54c1\u7684\u6a5f\u6703\u76f8\u5c0d\u8f03\u9ad8", "C": "\u4f7f\u7528\u7b2c\u4e00\u7d1a\u3001\u7b2c\u4e8c\u7d1a\u6216\u7b2c\u4e09\u7d1a\u6bd2\u54c1\u8005\uff0c\u4e00\u65e6\u88ab\u67e5\u7372\uff0c\u4e00\u5f8b\u6703\u88ab\u6aa2\u5bdf\u5b98\u8d77\u8a34", "D": "\u6d77\u6d1b\u56e0\u6210\u766e\u8005\u70ba\u6212\u9664\u6bd2\u766e\uff0c\u5b9a\u671f\u524d\u5f80\u6307\u5b9a\u6a5f\u69cb\u9032\u884c\u7f8e\u6c99\u51ac\uff08methadone\uff09\u6cbb\u7642\uff0c\u6b64\u70ba\u66ff\u4ee3\u6027\u85e5\u7269\u7642\u6cd5", "answer": "3"}, {"year": "110-1-2", "id": "13015", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u6709\u4e00\u7a2e\u770b\u6cd5\uff0c\u8a8d\u70ba\u5927\u773e\u5a92\u9ad4\uff08\u5982\u96fb\u5f71\u3001\u96fb\u8996\u6216\u793e\u4ea4\u5a92\u9ad4\uff09\u5e38\u5e38\u51fa\u73fe\u66b4\u529b\u7684\u82f1\u96c4\u4e3b\u7fa9\u93e1\u982d\uff0c\u9752\u5c11\u5e74\u9577\u671f\u89c0\u770b\u9019\u4e9b\u5a92\u9ad4\u4e4b\u5f8c\uff0c\u8a8d\u70ba\u5a92\u9ad4\u63cf\u7e6a\u60c5\u5883\u662f\u53cd\u6620\u4e86\u793e\u6703\u771f\u5be6\uff0c\u5c0e\u81f4\u5176\u66b4\u529b\u884c\u70ba\u7522\u751f\u3002\u4e0a\u8ff0\u662f\u61c9\u7528\u4f55\u7a2e\u50b3\u64ad\u7406\u8ad6\u5f71\u97ff\u9752\u5c11\u5e74\u7684\u5065\u5eb7\u884c\u70ba\uff1f", "qimg": "0", "A": "\u5275\u65b0\u64f4\u6563\uff08diffusion of innovation \uff09", "B": "\u5a92\u9ad4\u5021\u5c0e\uff08media advocacy\uff09", "C": "\u6db5\u5316\u7406\u8ad6\uff08cultivation theory\uff09", "D": "\u77e5\u6e9d\u7406\u8ad6\uff08knowledge gap theory\uff09", "answer": "3"}, {"year": "110-1-2", "id": "13016", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u4e0b\u5217\u6709\u95dc\u50b7\u5bb3\u9632\u5236\uff08injury prevention and control\uff09\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u6700\u4e0d\u6070\u7576\uff1f", "qimg": "0", "A": "\u50b7\u5bb3\u9632\u5236\u662f\u9810\u9632\u6709\u4eba\u84c4\u610f\uff0c\u5982\u5bb6\u66b4\u3001\u5152\u8650\u3001\u81ea\u6bba\u7b49\u6240\u9020\u6210\u7684\u50b7\u5bb3", "B": "\u50b7\u5bb3\u9632\u5236\u5fc5\u9808\u6709\u5404\u7a2e\u5c08\u696d\u9818\u57df\u4f86\u5171\u540c\u53c3\u8207\u52aa\u529b\uff0c\u5305\u62ec\u91ab\u5b78\u3001\u516c\u5171\u885b\u751f\u3001\u4ea4\u901a\u3001\u8b66\u653f\u3001\u6559\u80b2\u548c\u5a92\u9ad4\u7b49", "C": "\u6d41\u884c\u75c5\u5b78\u7684\u75be\u75c5\u4e09\u89d2\u6a21\u5f0f\u3014\u5bbf\u4e3b\uff08host\uff09\u2013\u4f5c\u56e0\uff08agent\uff09\u2013\u74b0\u5883\uff08environment\uff09\u3015\uff0c\u4e5f\u53ef\u4ee5\u7528\u4f86\u89e3\u91cb\u50b7\u5bb3\u7522\u751f\u7684\u5371\u96aa\u56e0\u5b50\uff0c\u4ee5\u64ec\u5b9a\u50b7\u5bb3\u9632\u5236\u7684\u7b56\u7565", "D": "\u50b7\u5bb3\u9632\u5236\u662f\u5c0d\u6703\u9020\u6210\u50b7\u4ea1\u7684\u4e8b\u6545\u4f86\u627e\u51fa\u539f\u56e0\uff0c\u4e26\u5c07\u50b7\u5bb3\u63a7\u5236\u5728 \u5c0f\u7bc4\u570d", "answer": "1"}, {"year": "110-1-2", "id": "13017", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u4e0b\u5217\u4f55\u7a2e\u652f\u4ed8\u5236\u5ea6\u7684\u57fa\u6e96\u55ae\u4f4d \u5927\uff0c\u5c0d\u91ab\u7642\u670d\u52d9\u63d0\u4f9b\u8005\u7684\u7bc0\u7d04\u8a98\u56e0\u6700\u5927\uff1f", "qimg": "0", "A": "\u8ad6\u91cf\uff08\u8ad6\u9805\uff09\u8a08\u916c", "B": "\u8ad6\u65e5\u8a08\u916c", "C": "\u8ad6\u75c5\u4f8b\u8a08\u916c", "D": "\u8ad6\u4eba\u8a08\u916c", "answer": "4"}, {"year": "110-1-2", "id": "13018", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u95dc\u65bc\u4e16\u754c\u885b\u751f\u7d44\u7e54\uff08World Health Organization\uff09\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6700\u4e0d\u6070\u7576\uff1f", "qimg": "0", "A": "\u4e16\u754c\u885b\u751f\u7d44\u7e54\u7684 \u9ad8\u6b0a\u529b\u55ae\u4f4d\u662f\u4e16\u754c\u885b\u751f\u5927\u6703\uff08World Health Assembly\uff09", "B": "\u4e16\u754c\u885b\u751f\u7d44\u7e54\u7684\u4e3b\u8981\u529f\u80fd\u4e0d\u5305\u542b\u6280\u8853\u5408\u4f5c", "C": "\u4e16\u754c\u885b\u751f\u7d44\u7e54\u662f\u806f\u5408\u570b\u9ad4\u7cfb\u5167\u7684\u5c08\u9580\u6a5f\u69cb", "D": "\u7d93\u8cbb\u77ed\u7f3a\u8207\u7d44\u7e54\u6548\u7387\u4e0d\u5f70\u662f\u4e16\u754c\u885b\u751f\u7d44\u7e54\u9762\u81e8\u7684\u91cd\u5927\u6311\u6230", "answer": "2"}, {"year": "110-1-2", "id": "13019", "type": "\u516c\u5171\u885b\u751f\u5b78", "question": "\u95dc\u65bc\u5e73\u8861\u8a08\u5206\u5361\uff08balanced scorecard\uff09\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6700\u4e0d\u6070\u7576\uff1f", "qimg": "0", "A": "\u57fa\u672c\u7cbe\u795e\u5728\u65bc\u5c07\u7b56\u7565\u8f49\u63db\u6210\u5177\u9ad4\u884c\u52d5", "B": "\u4e00\u822c\u5305\u542b\u8ca1\u52d9\u3001\u9867\u5ba2\u3001\u4f01\u696d\u5167\u90e8\u6d41\u7a0b\u3001\u4f01\u696d\u5b78\u7fd2\u8207\u6210\u9577\u7b49\u56db\u500b\u69cb\u9762", "C": "\u5176\u4e2d\u8ca1\u52d9\u69cb\u9762\u70ba\u9818\u5148\u6307\u6a19\uff08leading indicator\uff09", "D": "\u5728\u975e\u71df\u5229\u4e8b\u696d\u55ae\u4f4d\uff0c\u53ef\u4ee5\u589e\u52a0\u54e1\u5de5\u88ab\u6388\u6b0a\u7a0b\u5ea6\u4e4b\u7b2c\u4e94\u69cb\u9762", "answer": "3"}, {"year": "110-1-2", "id": "13020", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u4f55\u8005\u5728\u7528\u85e5\u524d\u9808\u6aa2\u6e2cHLA\uff08human leukocyte antigen\uff09-B*5701\u57fa\u56e0\u578b\uff0c\u907f\u514d\u85e5\u7269\u9020\u6210\u5ee3\u6cdb\u6027\u76ae\u819a\u7d05\u75b9\u8207\u6c34\u75b1\uff1f", "qimg": "0", "A": "amoxicillin", "B": "carbamazepine", "C": "abacavir", "D": "allopurinol", "answer": "3"}, {"year": "110-1-2", "id": "13021", "type": "\u85e5\u7406\u5b78", "question": "\u95dc\u65bc\u6297\u751f\u7d20\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "ampicillin\u548camoxicillin\u7684\u5438\u6536\u4e0d\u6703\u53d7\u5230\u98f2\u98df\u7684\u5f71\u97ff", "B": "dicloxacillin\u5438\u6536\u6548\u679c\u5dee\u662f\u56e0\u70ba\u5728\u9178\u6027\u74b0\u5883\u4e2d\u4e0d\u7a69\u5b9a", "C": "amoxicillin\u7684\u6297\u85e5\u6027\u7522\u751f\u4e3b\u8981\u662f\u56e0\u70ba\u03b2-\u5167\u91af\u80fa\u9176\uff08\u03b2-lactamase\uff09\u7684\u7522\u751f", "D": "nafcillin\u4e3b\u8981\u7531\u814e\u81df\u6392\u6cc4", "answer": "3"}, {"year": "110-1-2", "id": "13022", "type": "\u85e5\u7406\u5b78", "question": "\u95dc\u65bc\u55ae\u682a\u6297\u9ad4\uff08monoclonal antibody\uff09\u7528\u65bc\u816b\u7624\u6cbb\u7642\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u4f7f\u7528alemtuzumab\u6cbb\u7642\u6162\u6027\u6dcb\u5df4\u7d30\u80de\u6027\u767d\u8840\u75c5\u8f03\u7121\u5f15\u767c\u6dcb\u5df4\u7d30\u80de\u6e1b\u5c11\uff08lymphopenia\uff09\u7684\u7591\u616e", "B": "bevacizumab\u53ef\u6291\u5236VEGF\u5c0d\u5167\u76ae\u7d30\u80de\u7684\u529f\u80fd\uff0c\u9069\u7528\u65bc\u624b\u8853\u5f8c\u5373\u6642\u6295\u85e5\u6cbb\u7642", "C": "catumaxomab\u53ef\u540c\u6642\u4f5c\u7528\u5728\u816b\u7624\u53caT\u7d30\u80de\u4e0a\u800c\u767c\u63ee\u7642\u6548", "D": "cetuximab\u8207ramucirumab\u7684\u4f5c\u7528\u6a5f\u8f49\u540c\u6a23\u90fd\u662f\u963b\u65b7\u816b\u7624\u7d30\u80de\u7684EGFR\u6d3b\u6027", "answer": "3"}, {"year": "110-1-2", "id": "13023", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u6297\u764c\u85e5\u7269\u4e2d\uff0c\u4f55\u8005\u53ef\u6291\u5236topoisomerase II\uff0c\u5c0e\u81f4\u764c\u7d30\u80de\u4e4b DNA \u65b7\u88c2\u800c\u7522\u751f\u6297\u764c\u4f5c\u7528\uff1f", "qimg": "0", "A": "busulfan", "B": "cyclophosphamide", "C": "idarubicin", "D": "methotrexate", "answer": "3"}, {"year": "110-1-2", "id": "13024", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u4f55\u8005\u70ba\u6297\u764c\u5408\u4f75\u7642\u6cd5CMF\u6cbb\u7642\u4e73\u764c\u85e5\u7269\uff0c\u4e14\u5c6c\u65bcpyrimidine\u985e\u4f3c\u7269\uff0c\u5176\u6d3b\u6027\u4ee3\u8b1d\u7522\u7269\u53ef\u6291\u5236thymidylatesynthase\uff1f", "qimg": "0", "A": "5-fluorouracil", "B": "cytarabine", "C": "methotrexate", "D": "vincristine", "answer": "1"}, {"year": "110-1-2", "id": "13025", "type": "\u85e5\u7406\u5b78", "question": "\u95dc\u65bc\u6cbb\u7642\u504f\u982d\u75db\u85e5\u7269sumatriptan \u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u5176\u4f5c\u7528\u6a5f\u5236\u5728\u65bc\u62ee\u62975-HT1B/1D", "B": "\u8207\u6297\u6182\u9b31\u85e5SSRI\u4f75\u7528\u53ef\u80fd\u5c0e\u81f4serotonin syndrome", "C": "\u51a0\u72c0\u52d5\u8108\u75be\u75c5\uff08coronary artery disease\uff09\u75c5\u4eba\u70ba\u4f7f\u7528\u7981\u5fcc", "D": "\u53ef\u5f15\u8d77\u8166\u90e8\u8840\u7ba1\u6536\u7e2e", "answer": "1"}, {"year": "110-1-2", "id": "13026", "type": "\u85e5\u7406\u5b78", "question": "\u95dc\u65bcfenofibrate\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u53ef\u6d3b\u5316\u809d\u81df\u8102\u80aa\u9178\u6c27\u5316\u53cd\u61c9", "B": "\u53ef\u6d3b\u5316PPAR-\u03b1\u53d7\u9ad4", "C": "\u4e3b\u8981\u526f\u4f5c\u7528\u70ba\u808c\u8089\u75c5\u8b8a\u53ca\u809d\u529f\u80fd\u7570\u5e38", "D": "\u5177\u6291\u5236lipoprotein lipase\u6d3b\u6027", "answer": "4"}, {"year": "110-1-2", "id": "13027", "type": "\u85e5\u7406\u5b78", "question": "\u6771\u4eac\u5967\u6797\u5339\u514b\u904b\u52d5\u6703\u91dd\u5c0d\u904b\u52d5\u54e1\u4e4b\u7981\u85e5\u6aa2\u9a57\uff0c\u5176\u4e2derythropoietin\uff08EPO\uff09\u88ab\u5217\u70ba\u91cd\u8981\u7be9\u6aa2\u9805\u76ee\uff0c\u4e0b\u5217\u6709\u95dcEPO\u4e4b\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "darbepoetin alfa\u70baEPO\u985e\u4f3c\u7269", "B": "\u5e38\u898b\u526f\u4f5c\u7528\u70ba\u9ad8\u8840\u58d3\u53ca\u8840\u6813\u75c7", "C": "\u53d7\u9ad4\u6d3b\u5316ERK\u8a0a\u606f", "D": "\u523a\u6fc0\u7d05\u8840\u7403\u5e79\u7d30\u80de\u589e\u6b96\u53ca\u5206\u5316", "answer": "3"}, {"year": "110-1-2", "id": "13028", "type": "\u85e5\u7406\u5b78", "question": "\u6709\u95dcdesmopressin\u4fc3\u9032\u51dd\u8840\u4f5c\u7528\u7684\u6a5f\u8f49\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u4fc3\u9032plasminogen\u6d3b\u5316", "B": "\u8abf\u7bc0\u51dd\u8840\u56e0\u5b50factor VIII\u7684\u91cb\u653e", "C": "\u589e\u52a0cyclic AMP\u7684\u5206\u89e3", "D": "\u6d3b\u5316ADP receptor", "answer": "2"}, {"year": "110-1-2", "id": "13029", "type": "\u85e5\u7406\u5b78", "question": "\u674e\u592a\u592a \u8fd1\u534a\u5e74\u51fa\u73fe\u5fc3\u60b8\u3001\u624b\u6296\u3001\u51f8\u773c\u7b49\u75c7\u72c0\uff0c\u5230\u91ab\u9662\u5c31\u8a3a\u5f8c\u767c\u73fe\u6709\u7532\u72c0\u817a\u6a5f\u80fd\u4ea2\u9032\uff08hyperthyroidism\uff09\u7684\u60c5\u6cc1\u3002\u4e0b\u5217\u85e5\u7269\u90a3\u4e00\u7a2e\u6bd4\u8f03\u4e0d\u9069\u5408\u5979\uff1f", "qimg": "0", "A": "propylthiouracil", "B": "levothyroxine", "C": "Lugol's solution", "D": "propranolol", "answer": "2"}, {"year": "110-1-2", "id": "13030", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u4f55\u7a2e\u964d\u8840\u7cd6\u85e5\uff0c\u8f03\u9069\u5408\u7528\u65bc\u7b2c\u4e00\u578b\u7cd6\u5c3f\u75c5\uff1f", "qimg": "0", "A": "dapagliflozin", "B": "sitagliptin", "C": "insulin", "D": "glipizide", "answer": "3"}, {"year": "110-1-2", "id": "13031", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u4f55\u7a2e\u75be\u75c5\u6bd4\u8f03\u4e0d\u9069\u5408\u4f7f\u7528\u985e\u56fa\u9187/\u7cd6\u76ae\u8cea\u6fc0\u7d20\u6cbb\u7642\uff1f", "qimg": "0", "A": "\u611b\u8fea\u751f\u6c0f\u75c5\uff08Addison's disease\uff09", "B": "\u767c\u708e\u6027\u8178\u9053\u75be\u75c5\uff08inflammatory bowel disease\uff09", "C": "\u6d88\u5316\u6027\u6f70\u760d\uff08peptic ulcer\uff09", "D": "\u6c23\u5598\uff08asthma\uff09", "answer": "3"}, {"year": "110-1-2", "id": "13032", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u4f55\u8005\u70baD1-dopamine receptor agonist\uff0c\u53ef\u4ee5\u505a\u70ba\u964d\u8840\u58d3\u85e5\u7269\uff1f", "qimg": "0", "A": "clonidine", "B": "diazoxide", "C": "fenoldopam", "D": "ketanserin", "answer": "3"}, {"year": "110-1-2", "id": "13033", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u6709\u95dcacetazolamide\u5229\u5c3f\u5291\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u4f5c\u7528\u65bc\u9060\u66f2\u5c0f\u7ba1\u4f4d\u7f6e", "B": "\u53ef\u7528\u65bc\u6cbb\u7642\u9752\u5149\u773c", "C": "\u6613\u9020\u6210\u8033\u6bd2\u6027", "D": "\u6703\u5f15\u8d77\u9ad8\u8840\u9240", "answer": "2"}, {"year": "110-1-2", "id": "13034", "type": "\u85e5\u7406\u5b78", "question": "\u6d3b\u5316alpha-1\u4ea4\u611f\u53d7\u9ad4\uff08alpha-1 adrenoceptor\uff09\u53ef\u80fd\u5f15\u8d77\u4eba\u9ad4\u7522\u751f\u7684\u53cd\u61c9\u4e2d\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u8180\u80f1\u903c\u5c3f\u808c\uff08detrusor muscle\uff09\u6536\u7e2e", "B": "\u8c4e\u6bdb\u808c\uff08pilomotor muscle\uff09\u6536\u7e2e", "C": "\u9aa8\u9abc\u808c\u4e2d\u8840\u7ba1\u6536\u7e2e", "D": "\u5fc3\u808c\u6536\u7e2e\u529b\u589e\u5f37", "answer": "1"}, {"year": "110-1-2", "id": "13035", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u6297\u8548\u6bd2\u6027\u85e5\u7269\uff08antimuscarinic drug\uff09\u4e2d\uff0c\u4f55\u8005\u4e0d\u6613\u901a\u904e\u8840\u8166\u5c4f\u969c\uff08blood-brain barrier\uff09\uff0c\u56e0\u6b64\u5176\u5438\u5165\u6027\uff08inhalational\uff09\u5291\u578b\u9069\u5408\u7528\u65bc\u8212\u5f35\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5\uff08chronic obstructive pulmonary disease\uff09\u60a3\u8005\u4e4b\u6c23\u7ba1\uff0c\u4e14\u534a\u8870\u671f\u53ef\u9577\u905425\u5c0f\u6642\uff1f", "qimg": "0", "A": "tropicamide", "B": "ipratropium", "C": "tiotropium", "D": "benztropine", "answer": "3"}, {"year": "110-1-2", "id": "13036", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u4f55\u7a2e\u5438\u5165\u578b\u6c23\u5598\u85e5\u7269\uff0c\u900f\u904e\u8a08\u91cf\u5438\u5165\u5668\uff08metered-dose inhaler\uff09\u4f7f\u7528\u6642\uff0c\u4e3b\u8981\u53ea\u4f5c\u7528\u5728\u80ba\u81df\uff0c\u77ed\u6548\u4e14\u5e7e\u4e4e\u7121\u751f\u9ad4\u53ef\u7528\u7387\uff08bioavailability\uff09\uff1f", "qimg": "0", "A": "albuterol", "B": "montelukast", "C": "flunisolide", "D": "tiotropium", "answer": "1"}, {"year": "110-1-2", "id": "13037", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217H2\u53d7\u9ad4\u62ee\u6297\u5291\uff08H2-receptor antagonist\uff09\u9593\u7684\u4f5c\u7528\u5f37\u5ea6\uff08potency\uff09\u5dee\u7570\u53ef\u905450\u500d\uff0c\u5176\u4e2d\u4f55\u8005\u6291\u5236\u80c3\u9178\u5206\u6ccc\u7684\u4f5c\u7528\u5f37\u5ea6 \u5f37\uff1f", "qimg": "0", "A": "cimetidine", "B": "ranitidine", "C": "nizatidine", "D": "famotidine", "answer": "4"}, {"year": "110-1-2", "id": "13038", "type": "\u85e5\u7406\u5b78", "question": "\u7761\u7720\u5931\u8abf\u7684\u75c5\u4eba\uff0c\u53ef\u4ee5\u4f7f\u7528\u4e0b\u5217\u4f55\u7a2e\u85e5\u7269\u4f86\u6cbb\u7642\uff0c\u8a72\u85e5\u7269\u662fMT1\u548cMT2\u7684\u81f4\u6548\u5291\uff08agonist\uff09\uff1f", "qimg": "0", "A": "tasimelteon", "B": "sumatriptan", "C": "repinotan", "D": "orlistat", "answer": "1"}, {"year": "110-1-2", "id": "13039", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u4f55\u7a2e\u85e5\u7269 \u9069\u5408\u7528\u4f86\u6cbb\u7642\u9685\u89d2\u958b\u653e\u6027\u9752\u5149\u773c\uff08open-angle glaucoma\uff09\uff1f", "qimg": "0", "A": "alprostadil", "B": "latanoprost", "C": "misoprostol", "D": "dinoprostone", "answer": "2"}, {"year": "110-1-2", "id": "13040", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u4f55\u7a2e\u85e5\u7269\u53ef\u4ee5\u6709\u6548\u6cbb\u7642\u75db\u98a8\u75c5\u4eba\u7684\u6162\u6027\u9ad8\u5c3f\u9178\u8840\u75c7\uff08chronic hyperuricemia\uff09\uff1f", "qimg": "0", "A": "tramadol", "B": "rilonacept", "C": "ketorolac", "D": "febuxostat", "answer": "4"}, {"year": "110-1-2", "id": "13041", "type": "\u85e5\u7406\u5b78", "question": "\u6cbb\u7642\u601d\u89ba\u5931\u8abf\u75c7\uff08schizophrenia\uff09\u7684\u85e5\u7269\uff0c\u4e0b\u5217\u4f55\u8005\u6709 \u986f\u8457\u7684\u9310\u9ad4\u5916\u75c7\u5019\u7fa4\uff08extrapyramidal syndrome\uff09\u7684\u526f\u4f5c\u7528\uff1f", "qimg": "0", "A": "haloperidol", "B": "clozapine", "C": "olanzapine", "D": "aripiprazole", "answer": "1"}, {"year": "110-1-2", "id": "13042", "type": "\u85e5\u7406\u5b78", "question": "\u4e0b\u5217\u85e5\u7269\u4f55\u8005\u4e0d\u6613\u9020\u6210\u7cbe\u795e\u4f9d\u8cf4\u6027\uff08psychological dependence\uff09\uff1f", "qimg": "0", "A": "cocaine", "B": "psilocybin", "C": "ketamine", "D": "naloxone", "answer": "4"}, {"year": "110-1-2", "id": "13043", "type": "\u85e5\u7406\u5b78", "question": "\u95dc\u65bc\u6297\u7126\u616e\u85e5\u7269buspirone\u7684\u4f5c\u7528\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u6c92\u6709\u6297\u62bd\u6410\u6216\u808c\u8089\u9b06\u5f1b\u7684\u4f5c\u7528", "B": "\u4e3b\u8981\u4f5c\u7528\u5728\u8166\u90e8\u7684GABAA\u53d7\u9ad4", "C": "\u4e0d\u6703\u589e\u5f37\u9152\u7cbe\u7684\u4f5c\u7528", "D": "\u670d\u7528\u6578\u9031\u5f8c\u6297\u7126\u616e\u4f5c\u7528\u624d\u6703\u986f\u73fe", "answer": "2"}, {"year": "110-1-2", "id": "13044", "type": "\u85e5\u7406\u5b78", "question": "\u5c0d\u65bc\u904e\u91cfpropranolol\u5c0e\u81f4\u4f4e\u8840\u58d3\u548c\u5fc3\u8df3\u904e\u6162\uff0c\u4e0b\u5217\u4f55\u7a2e\u89e3\u6bd2\u5291\uff08antidote\uff09\u6548\u679c\u6700\u4f73\uff1f", "qimg": "0", "A": "glucagon", "B": "atropine", "C": "digoxin", "D": "pralidoxime", "answer": "1"}, {"year": "110-1-2", "id": "13045", "type": "\u75c5\u7406\u5b78", "question": "\u985e\u7e96\u7dad\u86cb\u767d\u6027\u58de\u6b7b\uff08fibrinoid necrosis\uff09 \u5e38\u51fa\u73fe\u65bc\u4e0b\u5217\u4f55\u7a2e\u60c5\u6cc1\uff1f", "qimg": "0", "A": "\u7d50\u6838\uff08tuberculosis\uff09", "B": "\u8166\u6897\u585e\uff08brain infarct\uff09", "C": "\u8840\u7ba1\u708e\uff08vasculitis\uff09", "D": "\u6025\u6027\u80f0\u81df\u708e\uff08acute pancreatitis\uff09", "answer": "3"}, {"year": "110-1-2", "id": "13046", "type": "\u75c5\u7406\u5b78", "question": "\u53d7\u50b7\u5f8c\uff0c\u7e96\u7dad\u6bcd\u7d30\u80de\uff08fibroblast\uff09\u53ca\u5fae\u8840\u7ba1\u589e\u751f\u65bc\u758f\u9b06\u7684\u9593\u8cea\u7d44\u7e54\u4e2d\uff0c\u4e26\u6df7\u5408\u8457\u767c\u708e\u7d30\u80de\uff0c\u70ba\u4e0b\u5217\u4f55\u8005\u7684\u7d44\u7e54\u5b78\u7279\u5fb5\uff1f", "qimg": "0", "A": "\u8089\u82bd\u816b\uff08granuloma\uff09", "B": "\u8089\u82bd\u7d44\u7e54\uff08granulation tissue\uff09", "C": "\u87f9\u8db3\u816b\uff08keloid\uff09", "D": "\u985e\u6fb1\u7c89\uff08amyloid\uff09", "answer": "2"}, {"year": "110-1-2", "id": "13047", "type": "\u75c5\u7406\u5b78", "question": "\u95dc\u65bc\u5168\u8eab\u6027\u7d05\u6591\u6027\u72fc\u7621\uff08systemic lupus erythematosus\uff09\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u814e\u7d72\u7403\u75c5\u8b8a\u4e3b\u8981\u662f\u56e0\u70ba\u5c0d\u6297\u814e\u7d72\u7403\u57fa\u5e95\u819c\uff08basement membrane\uff09\u81ea\u9ad4\u6297\u9ad4\u7684\u7522\u751f", "B": "\u6025\u6027\u8840\u7ba1\u708e\u4f75\u6709\u8840\u7ba1\u58c1\u51fa\u73fe\u985e\u7e96\u7dad\u86cb\u767d\u6027\u58de\u6b7b\uff08fibrinoid necrosis\uff09\u70ba\u5178\u578b\u7684\u75c5\u8b8a\u4e4b\u4e00", "C": "\u5728\u76ae\u819a\u7d44\u7e54\u88e1\uff0c\u81ea\u9ad4\u6297\u9ad4 \u4e3b\u8981\u6c89\u7a4d\u5728\u9c57\u72c0\u4e0a\u76ae\u7d30\u80de\u819c\u5468\u570d\uff0c\u9019\u662f\u5f15\u8d77\u6c34\u6ce1\u7684\u4e3b\u56e0", "D": "\u7d05\u8272\u9435\u7d72\u74b0\u69cb\u9020\u5f62\u6210\uff08wire-loop formation\uff09\u662f\u819c\u6027\u75c5\u8b8a\u578b\u72fc\u7621\u814e\u7d72\u7403\u814e\u708e\uff08membranous lupusglomerulonephritis\uff09\u7684\u5178\u578b\u8b8a\u5316\u4e4b\u4e00", "answer": "2"}, {"year": "110-1-2", "id": "13048", "type": "\u75c5\u7406\u5b78", "question": "\u93c8\u7403\u83cc\u611f\u67d3\u8f03\u5c11\u5f15\u8d77\u4e0b\u5217\u90a3\u4e00\u500b\u75c5\u8b8a\uff1f", "qimg": "0", "A": "\u5927\u8449\u6027\u80ba\u708e", "B": "\u58de\u6b7b\u6027\u8178\u708e", "C": "\u7329\u7d05\u71b1", "D": "\u814e\u5c0f\u7403\u814e\u708e", "answer": "2"}, {"year": "110-1-2", "id": "13049", "type": "\u75c5\u7406\u5b78", "question": "\u9ec3\u9eb4\u6bd2\u7d20\uff08aflatoxin B1\uff09\u4e4b\u81f4\u764c\u6a5f\u5236\uff0c\u4e3b\u8981\u662f\u9020\u6210\u4e0b\u5217\u4f55\u8005\u4e4b\u57fa\u56e0\u7a81\u8b8a\uff1f", "qimg": "0", "A": "MYC", "B": "RAS", "C": "RB", "D": "TP53", "answer": "4"}, {"year": "110-1-2", "id": "13050", "type": "\u75c5\u7406\u5b78", "question": "\u4e0b\u5217\u4f55\u8005\u70ba\u6700\u5e38\u65bc\u9020\u8840\u7cfb\u7d71\u60e1\u6027\u816b\u7624\u6d3b\u5316\u81f4\u764c\u57fa\u56e0\u4e4b\u67d3\u8272\u9ad4\u6838\u578b\u6539\u8b8a\uff08karyotypic change\uff09\uff1f", "qimg": "0", "A": "Translocation", "B": "Deletion", "C": "Gene amplification", "D": "Aneuploidy", "answer": "1"}, {"year": "110-1-2", "id": "13051", "type": "\u75c5\u7406\u5b78", "question": "\u4e00\u500b\u904e\u53bb\u8eab\u9ad4\u5065\u5eb7\u7684\u6210\u5e74\u75c5\u4eba\uff0c\u56e0\u70ba\u547c\u5438\u56f0\u96e3\u6c42\u91ab\uff0c\u91ab\u5e2b\u767c\u73fe\u75c5\u4eba\u6709\u660e\u986f\u7684\u80f8\u6c34\uff08pleural effusion\uff09\uff0c\u62bd\u51fa\u7684\u80f8\u6c34\u5448\u73fe\u4e73\u767d\u8272\u6df7\u6fc1\u6a23\uff0c\u80f8\u6c34\u7d93\u751f\u5316\u6aa2\u67e5\u5206\u6790\u542b\u6709\u9ad8\u6fc3\u5ea6\u7684\u4e09\u9178\u7518\u6cb9\u8102\uff08triglyceride\uff09\uff0c\u4e0b\u5217\u4f55\u8005\u662f\u9020\u6210\u75c5\u4eba\u80f8\u6c34\u7684\u6700\u53ef\u80fd\u539f\u56e0\uff1f", "qimg": "0", "A": "\u5fc3\u81df\u8870\u7aed", "B": "\u6dcb\u5df4\u7ba1\u963b\u585e", "C": "\u80ba\u6897\u585e\uff08lung infarct\uff09", "D": "\u4e0b\u8154\u975c\u8108\u963b\u585e", "answer": "2"}, {"year": "110-1-2", "id": "13052", "type": "\u75c5\u7406\u5b78", "question": "70\u6b72\u5973\u6027\uff0c\u5fc3\u81df\u8d85\u97f3\u6ce2\u6aa2\u67e5\u767c\u73fe\u4e8c\u5c16\u74e3\u51fa\u73fe\u9223\u5316\u7684\u73fe\u8c61\uff0c\u5fc3\u81df\u79d1\u91ab\u5e2b\u8a8d\u70ba\u8207\u9000\u5316\u6709\u95dc\uff0c\u4e0b\u5217\u6709\u95dc\u6b64\u75c5\u8b8a\u7684\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u9223\u5316 \u5bb9\u6613\u51fa\u73fe\u5728\u4e8c\u5c16\u74e3\u9023\u5408\u8655\uff08commissure of mitral valve\uff09", "B": "\u901a\u5e38\u6c92\u6709\u74e3\u819c\u529f\u80fd\u7684\u7570\u5e38", "C": "\u611f\u67d3\u6027\u5fc3\u5167\u819c\u708e\uff08infectious endocarditis\uff09\u7684\u98a8\u96aa\u589e\u52a0", "D": "\u5f15\u8d77\u8840\u6813\uff08thrombus\uff09\u7684\u6a5f\u6703\u589e\u52a0", "answer": "1"}, {"year": "110-1-2", "id": "13053", "type": "\u75c5\u7406\u5b78", "question": "\u6709\u95dc\u6162\u6027\u514d\u75ab\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u6027\u7d2b\u6591\u75c7\uff08chronic immune thrombocytopenic purpura\uff09\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u597d\u767c\u65bc60\u6b72\u4ee5\u4e0a\u7684\u8001\u5e74\u5973\u6027", "B": "\u75c5\u4eba\u8840\u6f3f\u4e2d\u6709\u5c0d\u6297\u8840\u5c0f\u677f\u7684\u81ea\u9ad4\u6297\u9ad4", "C": "\u9aa8\u9ad3\u5207\u7247\u53ef\u898b\u5de8\u6838\u7d30\u80de\uff08megakaryocytes\uff09\u986f\u8457\u6e1b\u5c11", "D": "\u591a\u6578\u75c5\u4eba\u5c0d\u91a3\u76ae\u8cea\u985e\u56fa\u9187\uff08glucocorticoid\uff09\u6cbb\u7642\u7f3a\u4e4f\u53cd\u61c9", "answer": "2"}, {"year": "110-1-2", "id": "13054", "type": "\u75c5\u7406\u5b78", "question": "\u6709\u95dc\u6162\u6027\u6dcb\u5df4\u7403\u6027\u767d\u8840\u75c5\uff08chronic lymphocytic leukemia\uff09\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u662f\u4e00\u7a2eT\u6dcb\u5df4\u7403\u7684\u60e1\u6027\u816b\u7624", "B": "\u597d\u767c\u65bc20\u6b72\u4ee5\u4e0b\u7684\u5152\u7ae5\u53ca\u5e74\u8f15\u4eba", "C": "\u5178\u578b\u816b\u7624\u7d30\u80de\u6703\u8868\u73feCD20\u3001CD5\u53caCD23", "D": "\u5927\u591a\u6578\u816b\u7624\u6703\u6709BCL2\u57fa\u56e0\u7684\u8f49\u4f4d\uff0c\u9020\u6210BCL2\u7684\u904e\u5ea6\u8868\u73fe", "answer": "3"}, {"year": "110-1-2", "id": "13055", "type": "\u75c5\u7406\u5b78", "question": "\u95dc\u65bc\u9f3b\u54bd\u4e0a\u76ae\u7d30\u80de\u764c\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u4e16\u754c\u885b\u751f\u7d44\u7e54\u4f9d\u5176\u7d44\u7e54\u5f62\u614b\uff0c\u4e3b\u8981\u5206\u70ba\u89d2\u5316\u578b\u9c57\u72c0\u4e0a\u76ae\u7d30\u80de\u764c\u3001\u975e\u89d2\u5316\u578b\u4e0a\u76ae\u7d30\u80de\u764c\u3001\u5206\u5316\u4e0d\u826f\u578b\u817a\u764c\u4e09\u7a2e", "B": "\u5229\u7528EBER-1\u539f\u4f4d\u96dc\u4ea4\u6cd5\uff0c\u5075\u6e2c\u75c5\u7406\u5207\u7247\u4e2d\u816b\u7624\u7d30\u80de\u6838\u5167\u542b\u6709Epstein-Barr\u75c5\u6bd2\u7684DNA\uff0c\u662f\u76ee\u524d\u4e3b\u8981\u7528\u4f86\u75c5\u7406\u8a3a\u65b7\u9f3b\u54bd\u4e0a\u76ae\u7d30\u80de\u764c\u7684\u4e3b\u8981\u5de5\u5177\u4e4b\u4e00", "C": "\u4e00\u822c\u8a8d\u70ba\u75c5\u4eba\u9810\u5f8c\u8207\u7d44\u7e54\u5f62\u614b\u578b\u5225\u7121\u95dc", "D": "\u89d2\u5316\u578b\u9c57\u72c0\u4e0a\u76ae\u7d30\u80de\u764c\u5c0d\u653e\u5c04\u6cbb\u7642\u7684\u53cd\u61c9\u8f03\u975e\u89d2\u5316\u578b\u7684\u816b\u7624\u5dee", "answer": "4"}, {"year": "110-1-2", "id": "13056", "type": "\u75c5\u7406\u5b78", "question": "\u7834\u58de\u80ba\u6ce1\u58c1\u5f48\u6027\u7e96\u7dad\uff08elastin\uff09\u800c\u9020\u6210\u80ba\u6c23\u816b\uff08emphysema\uff09\u7684\u86cb\u767d\u9176\u4e3b\u8981\u4f86\u81ea\uff1a", "qimg": "0", "A": "\u55dc\u4e2d\u6027\u767d\u8840\u7403", "B": "\u6dcb\u5df4\u7403", "C": "\u55dc\u9178\u6027\u767d\u8840\u7403", "D": "\u55dc\u9e7c\u6027\u767d\u8840\u7403", "answer": "1"}, {"year": "110-1-2", "id": "13057", "type": "\u75c5\u7406\u5b78", "question": "\u539f\u767c\u6027\u7e96\u6bdb\u904b\u52d5\u969c\u7919\uff08primary ciliary dyskinesia\uff09\u8f03\u5e38\u5f15\u8d77\u4e0b\u5217\u4f55\u7a2e\u80ba\u90e8\u75be\u75c5\uff1f", "qimg": "0", "A": "\u6162\u6027\u652f\u6c23\u7ba1\u708e", "B": "\u652f\u6c23\u7ba1\u64f4\u5f35", "C": "\u6c23\u5598", "D": "\u80ba\u6c23\u816b", "answer": "12"}, {"year": "110-1-2", "id": "13058", "type": "\u75c5\u7406\u5b78", "question": "\u4e0b\u5217\u90a3\u4e00\u7a2e\u809d\u708e\u75c5\u6bd2\u70ba\u53bb\u6c27\u6838\u91a3\u6838\u9178\u75c5\u6bd2\uff08DNA virus\uff09\uff1f", "qimg": "0", "A": "A\u578b\u809d\u708e\u75c5\u6bd2", "B": "B\u578b\u809d\u708e\u75c5\u6bd2", "C": "C\u578b\u809d\u708e\u75c5\u6bd2", "D": "D\u578b\u809d\u708e\u75c5\u6bd2", "answer": "2"}, {"year": "110-1-2", "id": "13059", "type": "\u75c5\u7406\u5b78", "question": "\u95dc\u65bc\u507d\u819c\u6027\u8178\u708e\uff08pseudomembranous colitis\uff09\u7684\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u8207\u6297\u751f\u7d20\u4f7f\u7528\u6709\u95dc", "B": "\u5b83\u901a\u5e38\u662f\u7531\u8271\u96e3\u68ad\u83cc\uff08Clostridium difficile\uff09\u5f15\u8d77\u7684", "C": "\u5728\u986f\u5fae\u93e1\u4e0b\uff0cpseudomembrane\u7531\u7834\u58de\u7684\u817a\u9ad4\u3001\u9ecf\u86cb\u767d\u548c\u8a31\u591a\u55dc\u4e2d\u6027\u767d\u8840\u7403\u7d44\u6210", "D": "\u901a\u5e38\u9700\u8981\u7d30\u83cc\u57f9\u990a\u4f86\u505a\u8a3a\u65b7", "answer": "4"}, {"year": "110-1-2", "id": "13060", "type": "\u75c5\u7406\u5b78", "question": "\u4ee5\u4e0b\u95dc\u65bc\u80c3\u764c\u7684\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u80c3\u764c\u7684\u767c\u75c5\u7387\u6709\u5730\u57df\u4e0a\u7684\u5dee\u7570\uff0c\u5728\u65e5\u672c\u7684\u767c\u751f\u7387\u6bd4\u5317\u7f8e\u9ad8", "B": "\u5bb6\u65cf\u6027\u80c3\u764c\u8207\u816b\u7624\u6291\u5236\u57fa\u56e0CDH1\u7684\u7a81\u8b8a\u6709\u5bc6\u5207\u76f8\u95dc", "C": "\u7030\u6f2b\u6027\u578b\u80c3\u764c\uff08diffuse gastric cancer\uff09\u8f03\u8178\u578b\u80c3\u764c\uff08intestinal type gastric cancer\uff09\u548c\u5e7d\u9580\u687f\u83cc\u6709\u5bc6\u5207\u76f8\u95dc", "D": "IL-1\u03b2\uff0cTNF\uff0cIL-10\uff0cIL-8\u548cTLR4\u7684\u57fa\u56e0\u8b8a\u7570\u8207\u5e7d\u9580\u687f\u83cc\u80c3\u708e\u76f8\u95dc\u7684\u80c3\u764c\u98a8\u96aa\u5347\u9ad8\u6709\u95dc", "answer": "3"}, {"year": "110-1-2", "id": "13061", "type": "\u75c5\u7406\u5b78", "question": "\u5916\u56e0\u6027\u4e4b\u76ae\u8cea\u9187\u589e\u591a\u75c7\uff0c\u814e\u4e0a\u817a\u6700\u6709\u53ef\u80fd\u7684\u75c5\u7406\u8b8a\u5316\u70ba\uff1a", "qimg": "0", "A": "\u76ae\u8cea\u840e\u7e2e", "B": "\u7030\u6f2b\u6027\u589e\u751f", "C": "\u5fae\u7d50\u7bc0\u6027\u589e\u751f", "D": "\u5de8\u7d50\u7bc0\u6027\u589e\u751f", "answer": "1"}, {"year": "110-1-2", "id": "13062", "type": "\u75c5\u7406\u5b78", "question": "\u9ec3\u8272\u8089\u82bd\u816b\u6027\u814e\u76c2\u814e\u708e\uff08xanthogranulomatous pyelonephritis\uff09 \u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70ba\uff1a", "qimg": "0", "A": "\u8b8a\u5f62\u687f\u83cc\uff08Proteus\uff09", "B": "\u7cde\u93c8\u7403\u83cc\uff08Streptococcus faecalis\uff09", "C": "\u514b\u96f7\u767d\u6c0f\u687f\u83cc\uff08Klebsiella\uff09", "D": "\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\uff08Staphylococcus aureus\uff09", "answer": "1"}, {"year": "110-1-2", "id": "13063", "type": "\u75c5\u7406\u5b78", "question": "\u7532\u72c0\u817a\u9ad3\u8cea\u764c\uff08medullary carcinoma\uff09\u5176\u816b\u7624\u7d30\u80de\u7684\u4f86\u6e90\u70ba\u4f55\uff1f\u5728\u816b\u7624\u7d30\u80de\u4e4b\u9593\u5e38\u53ef\u898b\u5230\u4f55\u7a2e\u8b8a\u5316\uff1f", "qimg": "0", "A": "\u7532\u72c0\u817aC\u7d30\u80de\uff08C-cell\uff09\uff1b\u7802\u6a23\u5c0f\u9ad4\uff08psammoma bodies\uff09", "B": "\u7532\u72c0\u817aC\u7d30\u80de\uff08C-cell\uff09\uff1b\u985e\u6fb1\u7c89\u6c89\u7a4d\uff08amyloid deposits\uff09", "C": "\u7532\u72c0\u817a\u6ffe\u6ce1\u7d30\u80de\uff08follicular cell\uff09\uff1b\u7802\u6a23\u5c0f\u9ad4\uff08psammoma bodies\uff09", "D": "\u7532\u72c0\u817a\u6ffe\u6ce1\u7d30\u80de\uff08follicular cell\uff09\uff1b\u985e\u6fb1\u7c89\u6c89\u7a4d\uff08amyloid deposits\uff09", "answer": "2"}, {"year": "110-1-2", "id": "13064", "type": "\u75c5\u7406\u5b78", "question": "\u4e0b\u5217\u6709\u95dc\u5375\u5de2\u6027\u7d22\u9593\u8cea\u7624\uff08sex cord stromal tumor\uff09\u7684\u6558\u8ff0\uff0c \u4f55\u8005\u8f03\u4e0d\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u6210\u4eba\u578b\u9846\u7c92\u7d30\u80de\u7624\uff08adult granulosa cell tumor\uff09\u7684\u81e8\u5e8a\u8868\u73fe\u70ba\u826f\u6027\u816b\u7624", "B": "\u6210\u4eba\u578b\u9846\u7c92\u7d30\u80de\u7624\uff08adult granulosa cell tumor\uff09\u53ef\u80fd\u6703\u5206\u6ccc\u52d5\u60c5\u6fc0\u7d20\uff08estrogen\uff09\uff0c\u800c\u8207\u589e\u751f\u6027\u4e73\u623f\u75be\u75c5\uff08proliferative breast disease\uff09\u3001\u5b50\u5bae\u5167\u819c\u589e\u751f\uff08endometrial hyperplasia\uff09\u7b49\u76f8\u95dc", "C": "\u652f\u6301\u9593\u8cea\u7d30\u80de\u7624\uff08Sertoli-Leydig cell tumor\uff09\u901a\u5e38\u5177\u6709\u8377\u723e\u8499\u529f\u80fd\u6027\uff08functional\uff09\uff0c\u5c0e\u81f4\u7537\u6027\u5316\uff08masculinization\uff09\u6216\u53bb\u5973\u6027\u5316\uff08defeminization\uff09", "D": "\u4e00\u534a\u4ee5\u4e0a\u7684\u652f\u6301\u9593\u8cea\u7d30\u80de\u7624\uff08Sertoli-Leydig cell tumor\uff09\u75c5\u4f8b\uff0c\u5176\u816b\u7624\u7d30\u80de\u5177\u6709 DICER1 \u57fa\u56e0\u7684\u7a81\u8b8a", "answer": "1"}, {"year": "110-1-2", "id": "13065", "type": "\u75c5\u7406\u5b78", "question": "\u4e0b\u5217\u6709\u95dc\u776a\u4e38\uff08testis\uff09\u8207\u9644\u776a\uff08epididymis\uff09\u767c\u708e\u7684\u6558\u8ff0\uff0c \u4f55\u8005\u8f03\u4e0d\u6b63\u78ba\uff1f", "qimg": "0", "A": "\u9644\u776a\uff08epididymis\uff09\u767c\u708e\u6bd4\u776a\u4e38\uff08testis\uff09\u767c\u708e\u66f4\u5e38\u898b", "B": "\u56e0\u7d50\u6838\u75c5\uff08tuberculosis\uff09\u5f15\u8d77\u7684\u767c\u708e\uff0c \u5148\u8d77\u65bc\u776a\u4e38", "C": "\u56e0\u6dcb\u75c5\uff08gonorrhea\uff09\u5f15\u8d77\u7684\u767c\u708e\uff0c \u5148\u8d77\u65bc\u9644\u776a", "D": "\u56e0\u6885\u6bd2\uff08syphilis\uff09\u5f15\u8d77\u7684\u767c\u708e\uff0c \u5148\u8d77\u65bc\u776a\u4e38", "answer": "2"}, {"year": "110-1-2", "id": "13066", "type": "\u75c5\u7406\u5b78", "question": "\u4e0b\u5217\u776a\u4e38\u816b\u7624\uff0c\u4f55\u8005\u6700\u5e38\u898b\u65bc\u4e09\u6b72\u4ee5\u4e0b\u7684\u5c0f\u5b69\uff1f", "qimg": "0", "A": "\u7cbe\u7d30\u80de\u7624\uff08seminoma\uff09", "B": "\u5375\u9ec3\u56ca\u7624\uff08yolk sac tumor\uff09", "C": "\u7d68\u6bdb\u764c\uff08choriocarcinoma\uff09", "D": "\u80da\u80ce\u764c\uff08embryonal carcinoma\uff09", "answer": "2"}, {"year": "110-1-2", "id": "13067", "type": "\u75c5\u7406\u5b78", "question": "\u4e0b\u5217\u6709\u95dc\u9aa8\u8089\u7624\uff08osteosarcoma\uff09\u7684\u63cf\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f", "qimg": "0", "A": "\u5927\u591a\u6578\u7684low-grade osteosarcoma\u56e0\u7b2c12\u5c0d\u67d3\u8272\u9ad4\u4e4b12q13-q15 amplification\uff0c\u81f4\u4f7fMYC\u86cb\u767d\u904e\u5ea6\u8868\u73fe", "B": "\u539f\u767c\u6027\u9aa8\u8089\u7624\uff08primary osteosarcoma\uff09\u597d\u767c\u65bc10~20\u6b72\u9752\u5c11\u5e74", "C": "\u674e\u2013\u4f5b\u7f8e\u5c3c\u75c7\u5019\u7fa4\uff08Li-Fraumeni syndrome\uff09\u60a3\u8005\uff0c\u56e0\u5e36\u6709germ-line TP53 gene mutations\uff0c\u6545\u7f79\u60a3\u9aa8\u8089\u7624\u7684\u767c\u751f\u7387\u8f03\u4e00\u822c\u4eba\u70ba\u9ad8", "D": "\u9aa8\u8089\u7624\u4e4b\u75c5\u7406\u8a3a\u65b7\u4e3b\u8981\u4f9d\u64da\u662f\u5728\u5207\u7247\u4e0a\u78ba\u5207\u89c0\u5bdf\u5230\u60e1\u6027\u7d30\u80de\u80fd\u7522\u751f\u985e\u9aa8\u7d44\u7e54\uff08osteoid\uff09", "answer": "1"}, {"year": "110-1-2", "id": "13068", "type": "\u75c5\u7406\u5b78", "question": "\u4e0b\u5217\u4f55\u8005\u662f\u963f\u8332\u6d77\u9ed8\u75c7\uff08Alzheimer disease\uff09\u60a3\u8005\u5927\u8166\u4e3b\u8981\u7684\u75c5\u7406\u8b8a\u5316\uff1f\u2460neuritic plaque \u2461neurofibrillarytangle \u2462nemaline rods \u2463Lewy body", "qimg": "0", "A": "\u2460\u2461", "B": "\u2460\u2462", "C": "\u2461\u2462", "D": "\u2461\u2463", "answer": "1"}, {"year": "110-1-2", "id": "13069", "type": "\u75c5\u7406\u5b78", "question": "\u4e0b\u5217\u4f55\u9805\u63cf\u8ff0\u8f03\u4e0d\u53ef\u80fd\u5728\u7b2c\u4e00\u578b\u55ae\u7d14\u75b1\u75b9\u75c5\u6bd2\u8166\u708e\u88ab\u89c0\u5bdf\u5230\uff1f", "qimg": "0", "A": "Cowdry type A intranuclear inclusion", "B": "perivascular lymphocytic cuff", "C": "microglial nodule", "D": "caseous necrotizing granuloma", "answer": "4"}]